KR100957776B1 - Novel Copolymer of [poly3-hydroxybutyrate-co-hydroxypropionate-co-lactate] and Method for Preparing the Same - Google Patents

Novel Copolymer of [poly3-hydroxybutyrate-co-hydroxypropionate-co-lactate] and Method for Preparing the Same Download PDF

Info

Publication number
KR100957776B1
KR100957776B1 KR1020060116233A KR20060116233A KR100957776B1 KR 100957776 B1 KR100957776 B1 KR 100957776B1 KR 1020060116233 A KR1020060116233 A KR 1020060116233A KR 20060116233 A KR20060116233 A KR 20060116233A KR 100957776 B1 KR100957776 B1 KR 100957776B1
Authority
KR
South Korea
Prior art keywords
coa
lactate
gene
hydroxypropionate
hydroxybutyrate
Prior art date
Application number
KR1020060116233A
Other languages
Korean (ko)
Other versions
KR20080046796A (en
Inventor
이상현
강혜옥
김태완
양택호
박시재
이상엽
이은정
Original Assignee
주식회사 엘지화학
한국과학기술원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to KR1020060116233A priority Critical patent/KR100957776B1/en
Application filed by 주식회사 엘지화학, 한국과학기술원 filed Critical 주식회사 엘지화학
Priority to US12/312,636 priority patent/US8765402B2/en
Priority to PCT/KR2007/005853 priority patent/WO2008062996A1/en
Priority to BRPI0718979-6A priority patent/BRPI0718979B1/en
Priority to CN200780043134XA priority patent/CN101616954B/en
Priority to EP07834159.1A priority patent/EP2087025B1/en
Priority to JP2009538326A priority patent/JP2010510372A/en
Priority to AU2007322529A priority patent/AU2007322529B2/en
Publication of KR20080046796A publication Critical patent/KR20080046796A/en
Application granted granted Critical
Publication of KR100957776B1 publication Critical patent/KR100957776B1/en
Priority to JP2013110698A priority patent/JP2013165734A/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/02Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
    • C08G63/06Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from hydroxycarboxylic acids
    • C08G63/08Lactones or lactides
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G61/00Macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain of the macromolecule
    • C08G61/12Macromolecular compounds containing atoms other than carbon in the main chain of the macromolecule
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/88Post-polymerisation treatment
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/40Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • C12P7/56Lactic acid
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y602/00Ligases forming carbon-sulfur bonds (6.2)
    • C12Y602/01Acid-Thiol Ligases (6.2.1)
    • C12Y602/010363-Hydroxypropionyl-CoA synthase (6.2.1.36)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

본 발명은 신규한 3-하이드록시부티레이트-3-하이드록시프로피오네이트-락테이트 삼중합체[poly(3-hydroxybutyrate-co-hydroxypropionate-co-lactate)] 및 그 제조방법에 관한 것으로, 더욱 자세하게는 락테이트(lactate)를 락틸-CoA(lactyl-CoA)로 전환하고 3-하이드록시알카노에트(3-hydroxyalkanoate)를 3-하이드록시알카노일-CoA(3-hydroxyalkanoyl-CoA)로 전환하는 효소의 유전자 및 폴리하이드록시알카노에트(polyhydroxyalkanoate:PHA) 합성효소 유전자를 동시에 가지는 세포 또는 식물을 이용하여 제조된 락테이트, 3-하이드록시프로피오네이트, 3-하이드록시부티레이트의 단량체로 이루어진 신규 삼중합체(3-하이드록시부티레이트-3-하이드록시프로피오네이트-락테이트 삼중합체)를 제조하는 방법 및 신규 3-하이드록시부티레이트-3-하이드록시프로피오네이트-락테이트 삼중합체에 관한 것이다.The present invention relates to a novel 3-hydroxybutyrate-3-hydroxypropionate-lactate terpolymer [poly (3-hydroxybutyrate-co-hydroxypropionate-co-lactate)] and a preparation method thereof, and more particularly, Of enzymes that convert lactate to lactyl-CoA and 3-hydroxyalkanoate to 3-hydroxyalkanoyl-CoA Novel terpolymer consisting of monomers of lactate, 3-hydroxypropionate and 3-hydroxybutyrate prepared using cells or plants having the gene and polyhydroxyalkanoate (PHA) synthase gene simultaneously A method for preparing (3-hydroxybutyrate-3-hydroxypropionate-lactate terpolymer) and a novel 3-hydroxybutyrate-3-hydroxypropionate-lactate terpolymer All.

본 발명에 따른 신규 3-하이드록시부티레이트-3-하이드록시프로피오네이트-락테이트는 생분해성 고분자로서 종래 합성 플라스틱의 용도를 대체할 수 있으며, 의료용으로도 사용이 가능하다.The novel 3-hydroxybutyrate-3-hydroxypropionate-lactate according to the present invention can replace the use of conventional synthetic plastics as biodegradable polymers and can also be used for medical purposes.

락테이트, 3-하이드록시프로피오네이트, 3-하이드록시부티레이트 Lactate, 3-hydroxypropionate, 3-hydroxybutyrate

Description

신규 3­하이드록시부티레이트­3­하이드록시프로피오네이트-락테이트 삼중합체 및 그 제조방법{Novel Copolymer of [poly(3-hydroxybutyrate-co-hydroxypropionate-co-lactate)] and Method for Preparing the Same}Novel Copolymer of [poly (3-hydroxybutyrate-co-hydroxypropionate-co-lactate)] and Method for Preparing the Same

도 1은 PHA 합성효소와 CP-PCT가 함께 발현되는 오페론 형태의 항시적 발현되는 시스템을 나타낸 모식도이다.Figure 1 is a schematic diagram showing a system of constant expression of the operon form in which PHA synthase and CP-PCT are expressed together.

도 2는 본 발명에 따른 PHA 합성효소 유전자와 CP-PCT 유전자를 포함하는 재조합 플라스미드 pPs619C1300-CPPCT의 계열지도를 나타낸 것이다.Figure 2 shows a sequence map of the recombinant plasmid pPs619C1300-CPPCT comprising the PHA synthase gene and CP-PCT gene according to the present invention.

도 3은 본 발명에 따른 PHA 합성효소 유전자와 CP-PCT 유전자를 포함하는 재조합 플라스미드 pTacCpPctNCvEC의 계열지도를 나타낸 것이다.Figure 3 shows a sequence map of the recombinant plasmid pTacCpPctNCvEC comprising the PHA synthase gene and CP-PCT gene according to the present invention.

도 4는 pPs619C1300-CPPCT 플라스미드로 형질전환된 재조합 대장균에 의해 생합성된 삼중합체의 성분을 분석한 가스크로마토그램 결과를 나타낸 것이다.Figure 4 shows the gas chromatogram results of analyzing the components of the terpolymer biosynthesized by recombinant E. coli transformed with the pPs619C1300-CPPCT plasmid.

도 5는 pTacCpPctNCvEC 플라스미드로 형질전환된 재조합 대장균에 의해 생합성된 삼중합체의 성분을 분석한 가스크로마토그램 결과를 나타낸 것이다.Figure 5 shows the gas chromatogram results of analyzing the components of the terpolymer biosynthesized by recombinant E. coli transformed with the pTacCpPctNCvEC plasmid.

발명의 분야Field of invention

본 발명은 신규한 3-하이드록시부티레이트-3-하이드록시프로피오네이트-락테이트 삼중합체[poly(3-hydroxybutyrate-co-hydroxypropionate-co-lactate)] 및 그 제조방법에 관한 것으로, 더욱 자세하게는 락테이트(lactate)를 락틸-CoA(lactyl-CoA)로 전환하고 3-하이드록시알카노에트(3-hydroxyalkanoate)를 3-하이드록시알카노일-CoA(3-hydroxyalkanoyl-CoA)로 전환하는 효소의 유전자 및 폴리하이드록시알카노에트(polyhydroxyalkanoate:PHA) 합성효소 유전자를 동시에 가지는 세포 또는 식물을 이용하여 제조된 락테이트, 3-하이드록시프로피오네이트, 3-하이드록시부티레이트의 단량체로 이루어진 신규 삼중합체(3-하이드록시부티레이트-3-하이드록시프로피오네이트-락테이트 삼중합체)를 제조하는 방법 및 신규 3-하이드록시부티레이트-3-하이드록시프로피오네이트-락테이트 삼중합체에 관한 것이다.The present invention relates to a novel 3-hydroxybutyrate-3-hydroxypropionate-lactate terpolymer [poly (3-hydroxybutyrate-co-hydroxypropionate-co-lactate)] and a preparation method thereof, and more particularly, Of enzymes that convert lactate to lactyl-CoA and 3-hydroxyalkanoate to 3-hydroxyalkanoyl-CoA Novel terpolymer consisting of monomers of lactate, 3-hydroxypropionate and 3-hydroxybutyrate prepared using cells or plants having the gene and polyhydroxyalkanoate (PHA) synthase gene simultaneously A method for preparing (3-hydroxybutyrate-3-hydroxypropionate-lactate terpolymer) and a novel 3-hydroxybutyrate-3-hydroxypropionate-lactate terpolymer All.

발명의 배경Background of the Invention

락테이트를 단량체로하는 중합체인 폴리락테이트(PLA)는 대표적인 생분해성 고분자로서 범용고분자 혹은 의료용 고분자로서의 응용성이 높은 고분자이다. 현재 PLA는 미생물 발효에 의해 생산된 락테이트를 중합하여 제조되고 있으나, 락테이트의 직접중합에 의해서는 낮은 분자량(1000-5000 달톤)의 PLA만이 생성된다. 100,000 달톤 이상의 PLA를 합성하기 위해서는 락테이트의 직접중합으로 얻어진 낮은 분자량의 PLA로부터 사슬 커플링제(chain coupling agent)를 이용하여 보다 분 자량이 큰 PLA로 중합하는 방법이 있으나 사슬 커플링제를 이용하기 때문에 고분자량의 PLA를 제조하는 방법은 유기용제나 커플링제의 첨가로 인해 공정이 복잡해지고, 또한 이들을 제거가 쉽지 않다는 단점이 있다. 현재 상용화되어있는 고분자량 PLA 생산공정은 락테이트를 락타이드(lactide)로 전환한 다음, 락타이드 링의 개환축합반응을 통해 PLA를 합성하는 화학합성 방법이 사용되고 있다. Polylactate (PLA), a polymer having lactate as a monomer, is a representative biodegradable polymer and has high applicability as a general purpose polymer or a medical polymer. Currently, PLA is produced by polymerizing lactate produced by microbial fermentation, but only low molecular weight (1000-5000 Daltons) PLA is produced by the direct polymerization of lactate. In order to synthesize 100,000 Daltons or more PLA, there is a method of polymerizing from a low molecular weight PLA obtained by direct polymerization of lactate to a PLA having a higher molecular weight using a chain coupling agent, but using a chain coupling agent. The method for producing high molecular weight PLA has a disadvantage in that the process is complicated by the addition of an organic solvent or a coupling agent, and it is not easy to remove them. Currently commercially available high molecular weight PLA production process is a chemical synthesis method of converting lactate to lactide (lactide), and then synthesize the PLA through the ring-opening condensation reaction of the lactide ring.

한편, PHA는 과도한 탄소원이 존재하면서 인, 질소, 마그네슘, 산소 등의 다른 영양분이 부족할 때, 미생물이 에너지나 탄소원 저장물질로 그 내부에 축적하는 폴리에스터(polyester)이다. PHA는 기존의 석유로부터 유래된 합성고분자와 비슷한 물성을 가지면서 완전한 생분해성을 보이기 때문에 기존의 합성 플라스틱을 대체할 물질로 인식되고 있다. On the other hand, PHAs are polyesters that microorganisms accumulate inside as energy or carbon source storage materials when there are excessive carbon sources and other nutrients such as phosphorus, nitrogen, magnesium, and oxygen are insufficient. PHA is regarded as a material to replace conventional synthetic plastics because it has properties similar to synthetic polymers derived from petroleum and shows complete biodegradability.

기존에 알려진 PHA는 대표적으로 짧은 탄소수를 가진 SCL-PHA (short-chain-length PHA)와 긴 탄소수를 가진 MCL-PHA (medium-chain-length PHA)로 나눌 수 있다. PHA를 합성하는 효소의 유전자는 Ralstonia eutropha, Pseudomonas 등으로부터 분리되었으며, 상기 PHA를 합성하는 효소 유전자가 형질전환된 재조합 미생물을 통해 다양한 종류의 단량체로 구성된 PHA가 합성되었다 (Qi et al., FEMS Microbiol . Lett., 157:155, 1997; Qi et al., FEMS Microbiol . Lett., 167:89, 1998; Langenbach et al., FEMS Microbiol . Lett., 150:303, 1997; WO 01/55436; US 6,143,952; WO 98/54329; WO 99/61624). Conventionally known PHAs can be classified into short-chain-length PHAs (SCL-PHAs) and medium-chain-length PHAs (MCL-PHAs) with long carbon atoms. The gene of the enzyme that synthesizes PHA is Ralstonia It was isolated from eutropha , Pseudomonas, etc., and PHA composed of various kinds of monomers was synthesized through the recombinant microorganism transformed with the enzyme gene synthesizing the PHA (Qi et al ., FEMS Microbiol . Lett ., 157: 155, 1997; Qi et al ., FEMS Microbiol . Lett ., 167: 89, 1998; Langenbach et al ., FEMS Microbiol . Lett ., 150: 303, 1997; WO 01/55436; US 6,143,952; WO 98/54329; WO 99/61624).

미생물에서 PHA를 생산하기 위해서는 미생물의 대사산물을 PHA 모노머로 전환해 주는 효소와 PHA 모노머를 이용하여 PHA 고분자를 합성하는 PHA 합성효 소(synthase)가 필수적이다. PHA 합성효소는 하이드록시아실-CoA(hydroxyacyl-CoA)를 기질로 사용하여 PHA를 합성하며, PHA의 기질인 하이드록시아실-CoA를 제공할 수 있는 효소로는 Ralstonia eutropha 등으로부터 유래된 α-케토티올레이즈(PhaA), 아세토아세틸-CoA 리덕테이즈(acetoacetyl-CoA reductase: PhaB), Pseudomonas로부터 유래된 3-하이드록시데카노일-ACP:CoA 트랜스퍼레이즈(3-hydroxydecanoyl-ACP:CoA transferase: PhaG), Aeromonas caviaePseudomonas aeruginosa로부터 유래된 (R)특이적 에놀-CoA 하이드라테이즈[(R)-specific enoyl-CoA hydratase: PhaJ] (Fukui et al., J. Bacteriol., 180:667, 1998; Tsuge et al., FEMS Microbiol. Lett., 184:193, 2000), 대장균과 Pseudomonas aeruginosa 등으로부터 유래된 3-케토아실-ACP 리덕테이즈(3-ketoacyl-ACP reductase: FabG) 등이 알려져 있다 (Taguchi et al., FEMS Microbiol. Lett., 176:183, 1999; Ren et al., J. Bacteriol., 182:2978, 2000; Park et al., FEMS Microbiol. Lett., 214:217, 2002). 이러한 효소들을 이용하여 다양한 탄소위치(주로 3, 4, 5, 6번 위치)에 하이드록실레이션된 하이드록시알카노에이트를 이용하여 다양한 종류의 PHA를 합성해 왔다. In order to produce PHA in microorganisms, enzymes for converting metabolites of microorganisms to PHA monomers and PHA synthase synthesizing PHA polymers using PHA monomers are essential. PHA synthase synthesizes PHA using hydroxyacyl-CoA as a substrate, and Ralstonia is an enzyme that can provide hydroxyacyl-CoA, a substrate of PHA. α-ketothiolase (PhaA) derived from eutropha et al., acetoacetyl-CoA reductase (PhaB), 3-hydroxydecanoyl-ACP: CoA transferase derived from Pseudomonas (3- hydroxydecanoyl-ACP: CoA transferase: PhaG), Aeromonas caviae and Pseudomonas The (R) derived from a specific enol aeruginosa -CoA hydroxy latte rise [(R) -specific enoyl-CoA hydratase: PhaJ] (Fukui et al ., J. Bacteriol ., 180: 667, 1998; Tsuge et al ., FEMS Microbiol. Lett ., 184: 193, 2000), Escherichia coli and Pseudomonas 3-ketoacyl-ACP reductase (FabG) derived from aeruginosa et al. is known (Taguchi et. al ., FEMS Microbiol. Lett ., 176: 183, 1999; Ren et al ., J. Bacteriol ., 182: 2978, 2000; Park et al ., FEMS Microbiol. Lett ., 214: 217, 2002). Various enzymes have been synthesized using hydroxyalkanoates hydroxylated at various carbon positions (mostly 3, 4, 5, 6) using these enzymes.

하지만 2번 위치가 하이드록실레이션된 하이드록시알카노에이트에 대한 PHA 합성효소의 반응성은 거의 없는 것으로 보고되어 있다 (Zhang et al., Appl . Microbiol . Biotechnol., 56:131, 2001; Valentin and Steinbuchel, Appl. Microbiol. Biotechnol., 40:699, 1994). 현재까지 락틸-CoA에 대한 PHA 중합효소의 in vitro 활성측정을 통해 PHA 합성효소의 락틸-CoA에 대한 반응성을 분석한 보 고가 있었으나, 락틸-CoA에 대한 PHA 합성효소의 반응성은 매우 미약하다 (Zhang et al., Appl . Microbiol . Biotechnol., 56:131, 2001; Valentin and Steinbuchel, Appl . Microbiol. Biotechnol., 40:699, 1994). 즉, 2번-탄소위치가 하이드록실레이션된 락테이트와 같은 하이드록시알카노에이트는 PHA 합성효소의 기질특이성에 적합하지 않아, 자연적으로 혹은 재조합 세포나 식물을 이용하여 PHA 및 그 삼중합체를 제조한 예는 없다. However, it has been reported that there is little reactivity of PHA synthase to hydroxylated hydroxyalkanoates at position 2 (Zhang et al. al ., Appl . Microbiol . Biotechnol ., 56: 131, 2001; Valentin and Steinbuchel, Appl. Microbiol. Biotechnol., 40: 699, 1994). To date in the PHA polymerase for raktil -CoA In vitro activity analysis of PHA synthase showed lactoly-CoA reactivity, but the reactivity of PHA synthase to lactyl-CoA was very weak (Zhang et al. al ., Appl . Microbiol . Biotechnol ., 56: 131, 2001; Valentin and Steinbuchel, Appl . Microbiol. Biotechnol ., 40: 699, 1994). That is, hydroxyalkanoates, such as 2-carbon-hydroxylated lactate, are not suitable for the substrate specificity of PHA synthase, so that PHA and its terpolymers can be produced naturally or using recombinant cells or plants. There is no example.

미국공개특허 20040076982에는 글루코오스에서 락테이트를 합성하고, 락테이트를 락틸-CoA로 생합성하고, 락틸-CoA로 3-하이드록시프로피오네이트(3-hydroxyalkanoate)-CoA를 생합성하는 방법이 개시되어 있으나, 락틸-CoA와 3-하이드록시프로피오네이트(3-hydroxyalkanoate)-CoA를 이용하여, 공중합체 또는 삼중합체를 제조하는 방법은 개시되어 있지 않다.US Patent Publication No. 20040076982 discloses a method of synthesizing lactate in glucose, biosynthesizing lactate with lactyl-CoA, and biosynthesis of 3-hydroxyalkanoate-CoA with lactyl-CoA. A method for preparing copolymers or terpolymers using lactyl-CoA and 3-hydroxyalkanoate-CoA is not disclosed.

이에, 본 발명자들은 미생물을 이용하여 고분자량의 3-하이드록시부티레이트-3-하이드록시프로피오네이트-락테이트 삼중합체를 제조하고자 예의 노력한 결과, 락테이트를 락틸-CoA(lactyl-CoA)로, 3-하이드록시알카노에이트(3-hydroxyalkanoate)를 3-하이드록시알카노일-CoA(3-hydroxyalkanoyl-CoA)로 전환하는 효소의 유전자인 Clostridium propionicum 유래 프로피놀-CoA 트랜스퍼라아제(propionyl-CoA transferase) 유전자(pct) 및 PHA 합성효소의 유전자로 형질전환된 재조합 대장균을 배양하는 것에 의하여, 3-하이드록시부티레이트-3-하이드록시프로피오네이트-락테이트 삼중합체가 생성되는 것을 확인하고 본 발명을 완성하게 되었다.  Accordingly, the present inventors have made intensive efforts to prepare high molecular weight 3-hydroxybutyrate-3-hydroxypropionate-lactate terpolymer using microorganisms, and as a result, lactate is converted into lactyl-CoA (lactyl-CoA) Clostridium , the gene for the enzyme that converts 3-hydroxyalkanoate to 3-hydroxyalkanoyl-CoA propionicum 3-hydroxybutyrate-3-hydroxypropionate- by culturing recombinant E. coli transformed with the derived propinol-CoA transferase gene ( pct ) and PHA synthase gene It was confirmed that the lactate terpolymer was produced and the present invention was completed.

본 발명의 목적은 신규 중합체인 3-하이드록시부티레이트-3-하이드록시프로피오네이트-락테이트 삼중합체[poly(3-hydroxybutyrate-co-hydroxypropionate-co-lactate)]를 제공하는데 있다.It is an object of the present invention to provide a novel polymer, 3-hydroxybutyrate-3-hydroxypropionate-lactate terpolymer [poly (3-hydroxybutyrate-co-hydroxypropionate-co-lactate)].

본 발명의 다른 목적은 상기 3-하이드록시부티레이트-3-하이드록시프로피오네이트-락테이트 삼중합체[poly(3-hydroxybutyrate-co-hydroxypropionate-co-lactate)]의 제조방법을 제공하데 있다.Another object of the present invention is to provide a method for preparing the 3-hydroxybutyrate-3-hydroxypropionate-lactate terpolymer [poly (3-hydroxybutyrate-co-hydroxypropionate-co-lactate)].

상기 목적을 달성하기 위하여, 본 발명은 락테이트와 3-하이드록시프로피오네이트 및 3-하이드록시부티레이트를 반복단위로 함유하는 3-하이드록시부티레이트-3-하이드록시프로피오네이트-락테이트 삼중합체 [poly(3-hydroxybutyrate-co-hydroxypropionate-co-lactate)]를 제공한다.In order to achieve the above object, the present invention is a 3-hydroxybutyrate-3-hydroxypropionate-lactate terpolymer containing lactate, 3-hydroxypropionate and 3-hydroxybutyrate as repeat units [poly (3-hydroxybutyrate-co-hydroxypropionate-co-lactate)].

본 발명은 또한, 락테이트(lactate)를 락틸-CoA(lactyl-CoA)로 전환하고 3-하이드록시알카노에트(3-hydroxyalkanoate)를 3-하이드록시알카노일-CoA(3-hydroxyalkanoyl-CoA)로 전환하는 효소의 유전자 및 폴리하이드록시알카노에트(polyhydroxyalkanoate:PHA) 합성효소 유전자를 동시에 가지는 세포 또는 식물을 배양 또는 재배하는 것을 특징으로 하는 3-하이드록시부티레이트-3-하이드록시프로피오네이트-락테이트 삼중합체 [poly(3-hydroxybutyrate-co-hydroxypropionate-co- lactate)]의 제조방법을 제공한다.The invention also converts lactate to lactyl-CoA and 3-hydroxyalkanoate to 3-hydroxyalkanoyl-CoA. 3-hydroxybutyrate-3-hydroxypropionate, characterized by culturing or cultivating cells or plants having both an enzyme gene and a polyhydroxyalkanoate (PHA) synthase gene converting to Provided is a method for preparing a lactate terpolymer [poly (3-hydroxybutyrate-co-hydroxypropionate-co-lactate)].

본 발명에 있어서, 세포 또는 식물은 PHA 합성효소 유전자를 가지지 않는 세포 또는 식물을 락테이트(lactate)를 락틸-CoA(lactyl-CoA)로 전환하고 3-하이드록시알카노에트(3-hydroxyalkanoate)를 3-하이드록시알카노일-CoA(3-hydroxyalkanoyl-CoA)로 전환하는 효소의 유전자 및 PHA 합성효소 유전자로 형질전환하여 수득되는 것임을 특징으로 할 수 있다.In the present invention, the cell or plant converts lactate to lactyl-CoA and converts 3-hydroxyalkanoate to cells or plants that do not have a PHA synthase gene. It may be characterized in that it is obtained by transformation with a gene of the enzyme to convert to 3-hydroxyalkanoyl-CoA (3-hydroxyalkanoyl-CoA) and PHA synthase gene.

본 발명에 있어서, 상기 락테이트(lactate)를 락틸-CoA(lactyl-CoA)로 전환하고 3-하이드록시알카노에트(3-hydroxyalkanoate)를 3-하이드록시알카노일-CoA(3-hydroxyalkanoyl-CoA)로 전환하는 효소의 유전자는 프로피오닐-CoA 트랜스퍼라아제 유전자(pct)인 것을 특징으로 할 수 있다.In the present invention, the lactate is converted to lactyl-CoA (lactyl-CoA) and 3-hydroxyalkanoate (3-hydroxyalkanoate) 3-hydroxyalkanoyl-CoA (3-hydroxyalkanoyl-CoA The gene of the enzyme to convert to) may be characterized in that the propionyl-CoA transferase gene ( pct ).

본 발명에 있어서, 상기 폴리하이드록시알카노에트(polyhydroxyalkanoate:PHA) 합성효소 유전자는 Pseudomonas sp. 6-19 유래의 phaC1ps6 -19인 것을 특징으로 할 수 있고, 상기 폴리하이드록시알카노에트(polyhydroxyalkanoate:PHA) 합성효소 유전자는 서열번호 7의 아미노산 서열에서 E130D, S325T 및 Q481M가 변이된 아미노산 서열을 코딩하는 유전자인 것을 특징으로 할 수 있다.In the present invention, the polyhydroxyalkanoate (PHA) synthase gene is Pseudomonas sp. It may be characterized in that the phaC1 ps6 -19 derived from 6-19, wherein the polyhydroxyalkanoate (PHA) synthase gene is an amino acid sequence of E130D, S325T and Q481M mutated in the amino acid sequence of SEQ ID NO: 7 It may be characterized in that the gene coding for.

본 발명에 있어서, 상기 세포는 미생물인 것을 특징으로 할 수 있고, 상기 미생물은 대장균인 것을 특징으로 할 수 있다.In the present invention, the cell may be characterized in that the microorganism, the microorganism may be characterized in that the E. coli.

본 발명에 있어서, 상기 배양 또는 재배는 3-하이드록시프로피오네이트(3- HP) 및 3-하이드록시부티레이트(3-HB)를 함유하는 환경에서 수행되는 것을 특징으로 할 수 있다. In the present invention, the culture or cultivation may be characterized in that it is carried out in an environment containing 3-hydroxypropionate (3-HP) and 3-hydroxybutyrate (3-HB).

상기 3-하이드록시부티레이트-3-하이드록시프로피오네이트-락테이트 삼중합체[poly(3-hydroxybutyrate-co-hydroxypropionate-co-lactate)] 생성능을 가지는 세포 또는 식물은 (i) 상기 두 유전자를 모두 가지지 않는 세포 또는 식물을 락테이트(lactate)를 락틸-CoA(lactyl-CoA)로 전환하고 3-하이드록시알카노에트(3-hydroxyalkanoate)를 3-하이드록시알카노일-CoA(3-hydroxyalkanoyl-CoA)로 전환하는 효소의 유전자와 lactyl-CoA를 기질로 사용하는 PHA 합성효소의 유전자로 형질전환하여 수득되거나, (ii) lactyl-CoA를 기질로 사용하는 PHA 합성효소의 유전자를 가지는 세포 또는 식물을 락테이트(lactate)를 락틸-CoA(lactyl-CoA)로 전환하고 3-하이드록시알카노에트(3-hydroxyalkanoate)를 3-하이드록시알카노일-CoA(3-hydroxyalkanoyl-CoA)로 전환하는 효소의 유전자로 형질전환하여 수득되거나, 또는 (iii) 락테이트(lactate)를 락틸-CoA(lactyl-CoA)로 전환하고 3-하이드록시알카노에트(3-hydroxyalkanoate)를 3-하이드록시알카노일-CoA(3-hydroxyalkanoyl-CoA)로 전환하는 효소의 유전자를 가지는 세포 또는 식물을 lactyl-CoA를 기질로 사용하는 PHA 합성효소의 유전자로 형질전환하여 수득되는 것을 특징으로 할 수 있으나, 이에 제한되는 것은 아니다.Cells or plants having the ability to generate 3-hydroxybutyrate-3-hydroxypropionate-lactate terpolymer [poly (3-hydroxybutyrate-co-hydroxypropionate-co-lactate)] are (i) both genes Cells or plants that do not have lactate are converted to lactyl-CoA and 3-hydroxyalkanoate to 3-hydroxyalkanoyl-CoA Cells or plants having a gene of PHA synthase using lactyl-CoA as a substrate or (ii) a gene of an enzyme converting to Of enzymes that convert lactate to lactyl-CoA and 3-hydroxyalkanoate to 3-hydroxyalkanoyl-CoA Obtained by transformation with the gene, or (iii) lactat e) converts lactyl-CoA (lactyl-CoA) and 3-hydroxyalkanoate to 3-hydroxyalkanoyl-CoA (3-hydroxyalkanoyl-CoA) Cells or plants may be obtained by transforming a gene of PHA synthase using lactyl-CoA as a substrate, but is not limited thereto.

상기 PHA 합성효소의 유전자를 가지는 세포로는 다양한 미생물이 알려져 있다 (KR 10-250830 B1). 예를 들면, Achromobacter sp., Achromobacter xylosoxidans 등을 포함하는 Achromobacter 속 미생물들, Acidovorax delafieldii, Acidovax facilis, Acinetobacter sp., Acinetobacter calcoaceticus, Acinetobacter lwoffii 등을 포함하는 Acinetobacter 속 미생물들, Actinomyces sp., Aeromonas caviae, Aeromonas hydrophila, Aeromonas salmonicida 등을 포함하는 Aeromonas 속 미생물들, Alcaligenes aestus, Alcaligenes denitrificans, Alcaligenes eutrophus (Ralstonia eutropha로 재명명된 후 다시 Wautersia eutropha로 재명명됨), Alcaligenes faecalis, Alcaligenes latus, Alcaligenes pacificus Alcaligenes paradoxus, Alcaligenes venestus 등을 포함하는 Alcaligenes 속 미생물들, Alteromonas macleodii, Amoebobacter roseu, Amoebobacter pendens 등을 포함하는 Amoebobacter 속 미생물들, Aphanocapa sp., Aphanothece sp. Aquaspirillum autotrophicum, Azorhizobium caulinodans, Azospirillum sp., Azospirillum brasilense, Azospirillum lipoferum 등을 포함하는 Azospirillum 속 미생물들, Azotobacter sp., Azotobacter agilis, Azotobacter chroococcum, Azotobacter macrocytogenes, Azotobacter vinelandii 등을 포함하는 Azotobacter 속 미생물들, Bacillus anthracis , Bacillus cereus , Bacillus megaterium , Bacillus subtillus, Bacillus thuringiensis 등을 포함하는 Bacillus 속 미생물들, Beggiatoa sp., Beggiatoa alba 등을 포함하는 Beggiatoa 속 미생물들, Beijerinckia indicus , Beijerinckia mobilis 등을 포함하는 Beijerinckia 속 미생물들, Beneckia natrigens , Beneckea pelagia 등을 포함하는 Beneckea 속 미생물들, Bordetella pertussis , Bradyrhizobium japonicum , Caryophamon latum , Caulobacter bacteroides, Caulobacter crescentus 등을 포함하는 Caulobacter 속 미생물들, Chloroflexus aurantiacus, Chlorogloea fritschii 등을 포함하는 Chlorogloea 속 미생물들, Chromatium minutissimum, Chromatium okenii , Chromatium tepidum 등을 포함하는 Chromatium 속 미생물들, Chromobacterium violaceum 등을 포함하는 Chromobacterium 속 미생물들, Clostridium botulinum, Clostridium sphenoides 등을 포함하는 Clostridium 속 미생물들, Comamonas acidovorans, Comamonas testosteroni 등을 포함하는 Comamonas 속 미생물들, Corynebacterium autotrophicum, Corynebacterium hydrocarboxydans 등을 포함하는 Corynebacterium 속 미생물들, Cyanobacteria, Derxia gummosa를 포함하는 Derxia 속 미생물들, Desulfococcus multivorans , Desulfonema limicola , Desulfonema magnum 등을 포함하는 Desulfonema 속 미생물들, Desulfosacina variabilis , Desulfovibrio sapovorans , Ectothiorhodospira halochloris , Ectothiorhodospira mobilis , Ectothiorhodospira vacuolata 등을 포함하는 Ectothiorhodospira 속 미생물들, Ferrobacillus ferroxidans , Flavobacterium sp., Haemophilus influenzae , Halobacterium gibbonsii, Halobacterium volcanii 등을 포함하는 Halobacterium 속 미생물들, Haloferax mediterranei, Hydroclathratus clathratus , Hydrogenomonas facilis , Hydrogenophaga flava , Hydrogenophaga pseudoflava , Hydrogenophaga taeniospiralis 등을 포함하는 Hydrogenophaga 속 미생물들, Hyphomicrobium vulgare를 포함하는 Hyphomicrobium 속 미생물들, Ilyobacter delafieldii, Labrys monachus , Lamprocystis reseopersicina , Lampropedia hyalina , Legionella sp., Leptothrix discophorus , Methylobacterium AM1, Methylobacterium extorquens 등을 포함하는 Methylobacterium 속 미생물들, Methylococcus thermophilus , Methlocystis parvus , Methylomonas methanica, Methylosinus sporium , Methylosinus trichosporium 등을 포함하는 Methylosinus 속 미생물들, Methylovibrio soehngenii , Micrococcus denitrificans , Micrococcus halodenitrificans 등을 포함하는 Micrococcus 속 미생물들, Mycobacterium album , Mycobacterium vacae 등을 포함하는 Mycobacterium 속 미생물들, Nitrobacter agilis , Nitrobacter winogradskyi 등을 포함하는 Nitrobacter 속 미생물들, Nocardia alba , Nocardia asteroides , Nocardia lucida , Nocardia rubra 등을 포함하는 Nocardia 속 미생물들, Paracoccus dentrificans , Oscillatoria limosa , Penicillium cyclopium, Photobacterium mandapamensis , Photobacterium phosphoreum 등을 포함하는 Photobacterium 속 미생물들, Physarum ploycephalumPseudomonas glathei , Pseudomonas indigofera, Pseudomonas lemonieri , Pseudomonas mallei , Pseudomonas marina , Pseudomonas mixta, Pseudomonas oleovorans , Pseudomonas oxalaticus , Pseudomonas pseudoalcaligenes , Pseudomonas aeruginosa , Pseudomonas alcaligenes , Pseudomonas asplenii , Pseudomonas butanovora, Pseudomonas cepacia , Pseudomonas coronafaciens , Pseudomonas dacunhae , Pseudomonas denitrificans , Pseudomonas diminuta , Pseudomonas echinoides , Pseudomonas fluorescens, Pseudomonas putida , Pseudomonas rubrilineas , Pseudomonas saccharophila , Pseudomonas stutzeri , Pseudomonas syringae , Pseudomonas thermophilus , Pseudomonas viridiflava 등을 포함하는 Pseudomonas 속 미생물들, Ralstonia 속 미생물들, Rhizobium hedysarum , Rhizobium lupini , Rhizobium meliloti , Rhizobium phaseoli , Rhizobium trifoli 등을 포함하는 Rhizobium 속 미생물들, Rhodobacillus 속 미생물들, Rhodobacter capsulatus , Rhodobacter sphaeroides 등을 포함하는 Rhodobacter 속 미생물들, Rhodococcus rhodochrous를 포함하는 Rhodococcus 속 미생물들, Rhodocyclus gelatinosus , Rhodocyclus tenuis 등을 포함하는 Rhodocyclus 속 미생물들, Rhodomicrobium vannielii Rhodopseudomonas acidophila , Rhodopseudomonas capsulata 등을 포함하는 Rhodopseudomonas 속 미생물들, Rhodospirillum molischianum, Rhodospirillum rubrum 등을 포함하는 Rhodospirillum 속 미생물들, Sphingomonas paucimobilis, Spirillum itersomii , Spirillum serpens 등을 포함하는 Spirillum 속 미생물들, Spirulina jenneri, Spirulina maxima , Spirulina subsaksa 등을 포함하는 Spirulina 속 미생물들, Staphylococcus aureus , Staphylococcus epidermidis , Staphylococcus xylosus 등을 포함하는 Staphylococcus 속 미생물들, Stella humosa , Stella vacuolata 등을 포함하는 Stella 속 미생물들, Streptomyces antibioticus , Streptomyces coelicolor 등을 포함하는 Streptomyces 속 미생물들, Syntrophomonas wolfei , Thermophilic cyanobacteria , Thermus thermophilus, Thiobacillus A2, Thiobacillus acidophilus , Thiobacillus versutus 등을 포함하는 Thiobacillus 속 미생물들, Thiocapsa pfennigii 등을 포함하는 Thiocapsa 속 미생물들, Thiocystis violacea, Vibrio parahaemolyticus, Xanthobacter autotrophicus , Xanthomonas maltophilia, Zoogloea ramigera 등을 포함하는 Zoogloea 속 미생물 등이 있다.Various microorganisms are known as cells having the gene of the PHA synthase (KR 10-250830 B1). For example,Achromobacter sp.,Achromobacter xylosoxidans IncludingAchromobacter Microorganisms,Acidovorax delafieldii,Acidovax facilis,Acinetobacter sp.,Acinetobacter calcoaceticus,Acinetobacter lwoffii IncludingAcinetobacter Microorganisms,Actinomyces sp.,Aeromonas caviae,Aeromonas hydrophila,Aeromonas salmonicida IncludingAeromonas Microorganisms,Alcaligenes aestus,Alcaligenes denitrificans,Alcaligenes eutrophus (Ralstonia eutrophaRenamed back toWautersia eutrophaRenamed to),Alcaligenes faecalis,Alcaligenes latus,Alcaligenes pacificus Alcaligenes paradoxus,Alcaligenes venestus IncludingAlcaligenes Microorganisms,Alteromonas macleodii,Amoebobacter roseu,Amoebobacter pendens IncludingAmoebobacter Microorganisms,Aphanocapa sp.,Aphanothece sp.Aquaspirillum autotrophicum,Azorhizobium caulinodans,Azospirillum sp.,Azospirillum brasilense,Azospirillum lipoferum IncludingAzospirillum Microorganisms,Azotobacter sp.,Azotobacter agilis,Azotobacter chroococcum,Azotobacter macrocytogenes,Azotobacter vinelandii IncludingAzotobacter Microorganisms,Bacillus anthracis , Bacillus cereus , Bacillus megaterium , Bacillus subtillus, Bacillus thuringiensis IncludingBacillus Microorganisms,Beggiatoa sp.,Beggiatoa alba IncludingBeggiatoa Microorganisms,Beijerinckia indicus , Beijerinckia mobilis IncludingBeijerinckia Microorganisms,Beneckia natrigens , Beneckea pelagia IncludingBeneckea Microorganisms,Bordetella pertussis , Bradyrhizobium japonicum , Caryophamon latum , Caulobacter bacteroides, Caulobacter crescentus IncludingCaulobacter Microorganisms,Chlororoflexus aurantiacus, Chlorogloea fritschii IncludingChlorogloea Microorganisms,Chromatium minutissimum, Chromatium okenii , Chromatium tepidum IncludingChromatium Microorganisms,Chromobacterium violaceum IncludingChromobacterium Microorganisms,Clostridium botulinum, Clostridium sphenoides IncludingClostridium Microorganisms,Comamonas acidovorans, Comamonas testosteroni IncludingComamonas Microorganisms,Corynebacterium autotrophicum, Corynebacterium hydrocarboxydans IncludingCorynebacterium Microorganisms,Cyanobacteria,Derxia gummosaContainingDerxia Microorganisms,Desulfococcus multivorans , Desulfonema limicola , Desulfonema magnum IncludingDesulfonema Microorganisms,Desulfosacina variabilis , Desulfovibrio sapovorans , Ectothiorhodospira halochloris , Ectothiorhodospira mobilis , Ectothiorhodospira vacuolata IncludingEctothiorhodospira Microorganisms,Ferrobacillus ferroxidans , Flavobacterium sp.,Haemophilus influenzae , Halobacterium gibbonsii, Halobacterium volcanii IncludingHalobacterium Microorganisms,Haloferax mediterranei, Hydroclathratus clathratus , Hydrogenomonas facilis , Hydrogenophaga flava , Hydrogenophaga pseudoflava , Hydrogenophaga taeniospiralis IncludingHydrogenophaga Microorganisms,Hyphomicrobium vulgareContainingHyphomicrobium Microorganisms,Ilyobacter delafieldii, Labrys monachus , Lamprocystis reseopersicina , Lampropedia hyalina , Legionella sp.,Leptothrix discophorus , Methylobacterium  AM1,Methylobacterium extorquens IncludingMethylobacterium Microorganisms,Methylococcus thermophilus , Methlocystis parvus , Methylomonas methanica, Methylosinus sporium , Methylosinus trichosporium IncludingMethylosinus Microorganisms,Methylovibrio soehngenii , Micrococcus denitrificans , Micrococcus halodenitrificans IncludingMicrococcus Microorganisms,Mycobacterium album , Mycobacterium vacae IncludingMycobacterium Microorganisms,Nitrobacter agilis , Nitrobacter winogradskyi IncludingNitrobacter Microorganisms,Nocardia alba , Nocardia asteroides , Nocardia lucida , Nocardia rubra IncludingNocardia Microorganisms,Paracoccus dentrificans , Oscillatoria limosa , Penicillium cyclopium, Photobacterium mandapamensis , Photobacterium phosphoreum IncludingPhotobacterium Microorganisms,Physarum ploycephalumWowPseudomonas glathei , Pseudomonas indigofera, Pseudomonas lemonieri , Pseudomonas mallei , Pseudomonas marina , Pseudomonas mixta, Pseudomonas oleovorans , Pseudomonas oxalaticus , Pseudomonas pseudoalcaligenes , Pseudomonas aeruginosa , Pseudomonas alcaligenes , Pseudomonas asplenii , Pseudomonas butanovora, Pseudomonas cepacia , Pseudomonas coronafaciens , Pseudomonas dacunhae , Pseudomonas denitrificans , Pseudomonas diminuta , Pseudomonas echinoides , Pseudomonas fluorescens, Pseudomonas putida , Pseudomonas rubrilineas , Pseudomonas saccharophila , Pseudomonas stutzeri , Pseudomonas syringae , Pseudomonas thermophilus , Pseudomonas viridiflava IncludingPseudomonas Microorganisms,Ralstonia Microorganisms,Rhizobium hedysarum , Rhizobium lupini , Rhizobium meliloti , Rhizobium phaseoli , Rhizobium trifoli IncludingRhizobium Microorganisms,Rhodobacillus Microorganisms,Rhodobacter capsulatus , Rhodobacter sphaeroides IncludingRhodobacter Microorganisms,Rhodococcus rhodochrousContainingRhodococcusMicroorganisms,Rhodocyclus gelatinosus , Rhodocyclus tenuis IncludingRhodocyclus Microorganisms,Rhodomicrobium vannielii Wow Rhodopseudomonas acidophila , Rhodopseudomonas capsulata IncludingRhodopseudomonas Microorganisms,Rhodospirillum molischianum, Rhodospirillum rubrum IncludingRhodospirillum Microorganisms,Sphingomonas paucimobilis, Spilrillum itersomii , Spilrillum serpens IncludingSpilrillum Microorganisms,Spirulina jenneri, Spirulina maxima , Spirulina subsaksa IncludingSpirulina Microorganisms,Staphylococcus aureus , Staphylococcus epidermidis , Staphylococcus xylosus IncludingStaphylococcus Microorganisms,Stella humosa , Stella vacuolata IncludingStella Microorganisms,Streptomyces antibioticus , Streptomyces coelicolor IncludingStreptomyces Microorganisms,Syntrophomonas wolfei , Thermophilic cyanobacteria , Thermus thermophilus,Thiobacillus A2,Thiobacillus acidophilus , Thiobacillus versutus IncludingThiobacillus Microorganisms,Thiocapsa pfennigii IncludingThiocapsa Microorganisms,Thiocystis violacea,Vibrio parahaemolyticus,Xanthobacter autotrophicus , Xanthomonas maltophilia, Zoogloea ramigera IncludingZoogloea Genus microorganisms.

본 발명에서 락테이트(lactate)를 락틸-CoA(lactyl-CoA)로 전환하고 3-하이드록시알카노에트(3-hydroxyalkanoate)를 3-하이드록시알카노일-CoA(3-hydroxyalkanoyl-CoA)로 전환하는 효소의 유전자 및 폴리하이드록시알카노에트(polyhydroxyalkanoate:PHA) 합성효소 유전자를 동시에 가지는 세포 또는 식물은 3-하이드록시프로피오네이트, 락테이트 및 3-하이드록시푸틸레이트를 포함하는 환경에서 배양 또는 재배하여 3-하이드록시부티레이트-3-하이드록시프로피오네이트-락테이트 삼중합체 [poly(3-hydroxybutyrate-co-hydroxypropionate-co-lactate)]를 제조할 수 있으며, 글루코오스나 시트릭산 등의 다른 탄소원으로부터 락테이트, 3-하이드록시프로피오네이트 및 3-하이드록시푸틸레이트를 생합성 할 수 있는는 세포 또는 식물이라면 별도로 첨가하지 않아도 상기 공중합체를 제조할 수 있다.In the present invention, lactate is converted to lactyl-CoA and 3-hydroxyalkanoate is converted to 3-hydroxyalkanoyl-CoA. Cells or plants having both the gene of the enzyme and the polyhydroxyalkanoate (PHA) synthase gene are cultured in an environment containing 3-hydroxypropionate, lactate and 3-hydroxyfutylate. It can be grown to produce 3-hydroxybutyrate-3-hydroxypropionate-lactate terpolymer [poly (3-hydroxybutyrate-co-hydroxypropionate-co-lactate)], and other carbon sources such as glucose or citric acid The copolymer can be prepared without additional addition if the cell or plant can biosynthesize lactate, 3-hydroxypropionate and 3-hydroxyfutylate from.

본 발명의 전환효소의 유전자 및 합성효소의 유전자를 함유하는 식물체를 제조하기 위한, 식물체의 형질감염은 아그로박테리움이나 바이러스 벡터 등을 이용한 통상의 방법에 의해 달성할 수 있다. 예컨대, 본 발명에 따른 유전자를 함유하는 재조합벡터로 아그로박테리움 속 미생물을 형질전환시킨 다음, 상기 형질전환된 아그로박테리움 속 미생물을 대상 식물의 조직 등에 감염시켜 형질감염된 식물을 수득할 수 있다. 보다 구체적으로, (a) 대상 식물의 외식체(explant)를 전 배양(pre-culture)한 다음, 이를 상기 형질전환된 아그로박테리움과 공동배양하여 형질감염시키는 단계; (b) 형질감염된 외식체를 캘러스 유도배지에서 배양하여, 캘러스를 수득하는 단계; 및 (c) 수득된 캘러스를 절단하고, 이를 신초 유도배지에서 배양하여 신초를 형성시키는 단계를 거쳐 형질감염된 식물을 제조할 수 있다. Transfection of a plant for producing a plant containing the gene of the converting enzyme of the present invention and the gene of the synthetase can be achieved by a conventional method using Agrobacterium, a viral vector or the like. For example, a microorganism of the genus Agrobacterium may be transformed with a recombinant vector containing a gene according to the present invention, and then the transformed Agrobacterium microorganism may be infected with tissues of a target plant to obtain a transfected plant. More specifically, (a) pre-culture the explant of the plant (preplant), and then transfected by co-culture with the transformed Agrobacterium; (b) culturing the transfected explants in a callus induction medium to obtain callus; And (c) cutting the obtained callus, and culturing it in shoot induction medium to form shoots, thereby producing a transfected plant.

본 발명에서 '외식체(explant)'라 함은 식물체에서 잘라낸 조직의 절편을 말하는 것으로, 자엽(cotyledon) 또는 하배축(hypocotyl)을 포함한다. 본 발명의 방법에 사용되는 식물의 외식체로는 자엽 또는 하배축을 사용할 수 있으며, 식물의 종자를 소독하고 세척한 후, MS 배지에서 발아시켜 얻은 자엽을 사용하는 것이 보다 바람직하다.  In the present invention, the term "explant" refers to a slice of tissue cut out of a plant, and includes cotyledon or hypocotyl. The explants of the plant used in the method of the present invention may be cotyledons or hypocotyls, it is more preferable to use the cotyledons obtained by germinating in MS medium after disinfecting and washing the seeds of the plants.

본 발명에서 이용가능한 형질감염 대상 식물로는 담배, 토마토, 고추, 콩, 벼, 옥수수 등을 들 수 있으나, 이에 한정되는 것은 아니다. 또한, 형질전환에 사용되는 식물이 유성번식 식물이라 할지라도, 조직배양 등에 의해 무성적으로 반복생식 시킬 수 있다는 것은 당업자에게 자명하다 할 것이다. Transfection target plants usable in the present invention include, but are not limited to, tobacco, tomatoes, peppers, beans, rice, corn, and the like. In addition, even if the plant used for transformation is a sexually propagating plant, it will be apparent to those skilled in the art that it can be repeatedly reproduced by tissue culture or the like.

이하 본 발명을 실시예에 의하여 더욱 상세하게 설명한다. 이들 실시예는 단지 본 발명을 보다 구체적으로 설명하기 위한 것으로, 본 발명의 범위가 이들 실시예에 국한되지 않는다는 것은 당업계에서 통상의 지식을 가진 자에게 있어서 자명할 것이다. Hereinafter, the present invention will be described in more detail with reference to Examples. These examples are only for illustrating the present invention in more detail, it will be apparent to those skilled in the art that the scope of the present invention is not limited to these examples.

실시예Example 1:  One: pctpct 유전자 및  Gene and PHAPHA 유전자를 함유한 재조합 플라스미드의 제작 Construction of Recombinant Plasmids Containing Genes

3-하이드록시프로피오네이트-락테이트 공중합체[poly(3-hydroxypropionate-co-lactate)]를 제조하기 위하여 pct 유전자와 PHA 유전자를 함유하는 재조합 플라스미드 pPs619C1300-CPPCT 및 pTacCpPctNCvEC를 제작하였다.To prepare a 3-hydroxypropionate-lactate copolymer [poly (3-hydroxypropionate-co-lactate)], recombinant plasmids pPs619C1300-CPPCT and pTacCpPctNCvEC containing the pct gene and the PHA gene were prepared.

(1) pPs619C1300-CPPCT 플라스미드의 제작(1) Preparation of pPs619C1300-CPPCT plasmid

pct 유전자는 클로스트리듐 프로피오니쿰(Clostridium propionicum) 유래의 프로피오닐-CoA 트랜스퍼라아제(pronpionyl-CoA transferase: CP-PCT) 유전자를 사용하였으며, PHA 합성효소 유전자는 슈도모나스 6-10( Pseudomonas sp. 6-19)의 PHA 합성효소 유전자를 사용하였다. The pct gene is Clostridium propionicum) propionyl -CoA transferase dehydratase (pronpionyl-CoA transferase derived from: was used as the CP-PCT) gene, PHA synthase gene is 6-10 Pseudomonas (Pseudomonas sp. 6-19) PHA synthase gene was used.

도 1과 같이 PHA 합성효소(synthase)와 CP-PCT가 함께 발현되는 오페론 형태의 항시적 발현되는 시스템을 구축하였다. CP-PCT의 경우 발현 시에 숙주 미생물에 대하여 강한 독성을 나타낸다고 알려져 있으며, 일반적으로 재조합 단백질 발현에 널리 사용되는 tac이나 T7 프로모터를 사용한 IPTG 발현유도 시스템에서는 발현유도 물질 첨가와 동시에 재조합 미생물이 모두 사멸한다. 이 때문에 약하게 발현되지만 미생물 성장에 따라 지속적으로 발현되는 항시적 발현되는 시스템을 사용하였다. CP-PCT 유전자는 Chostridium propionicum (DSMZ1682) 의 염색체 DNA를 주형으로 하고, pct 유전자 시퀀스(Selmer et al ., Eur J Biochem., 269:372, 2002)에 기반하여 제작된 서열번호 1 및 서열번호 2의 염기서열을 가지는 프라이머를 이용한 PCR을 수행하여 획득하였다.As shown in FIG. 1, a system for constitutive expression of operon in which PHA synthase and CP-PCT are expressed together was constructed. CP-PCT is known to be highly toxic to host microorganisms at the time of expression.In the IPTG expression system using tac or T7 promoters, which are widely used for recombinant protein expression, all recombinant microorganisms are killed at the same time as expression-inducing substances are added. do. For this reason, a constantly expressed system was used, which is weakly expressed but continuously expressed as the microorganism grows. CP-PCT gene is Chostridium propionicum Chromosomal DNA of (DSMZ1682) as a template, pct Gene sequence (Selmer et al . , Eur J Biochem. , 269: 372, 2002) was obtained by PCR using a primer having a nucleotide sequence of SEQ ID NO: 1 and SEQ ID NO: 2.

서열번호 1: 5-ggaattcATGAGAAAGGTTCCCATTATTACCGCAGATGASEQ ID NO: 5-ggaattcATGAGAAAGGTTCCCATTATTACCGCAGATGA

서열번호 2: 5-gctctagattaggacttcatttccttcagacccattaagccttctgSEQ ID NO: 5-gctctagattaggacttcatttccttcagacccattaagccttctg

이 때, 원래 야생형의 CP-PCT에 존재하는 NdeI 제한효소 부위를 클로닝의 용 이성을 위하여 SDM방법을 이용하여 제거하였다. 또, SbfI/NdeI 인식부위를 첨가하기 위해 서열번호 3과 4의 염기서열을 가지는 프라이머를 이용하여 오버랩핑 PCR을 수행하였다.At this time, the Nde I restriction enzyme site originally present in the wild-type CP-PCT was removed using the SDM method for ease of cloning. In addition, overlapping PCR was performed using primers having the nucleotide sequences of SEQ ID NOs: 3 and 4 to add the Sbf I / Nde I recognition sites.

서열번호 3: 5-agg cct gca ggc gga taa caa ttt cac aca gg- 3 SEQ ID NO: 5-agg cct gca ggc gga taa caa ttt cac aca gg- 3

서열번호 4: 5-gcc cat atg tct aga tta gga ctt cat ttc c- 3 SEQ ID NO: 5-gcc cat atg tct aga tta gga ctt cat ttc c- 3

Pseudomonas sp. 6-19(KCTC11027BP) 유래 PHA 합성효소(phaC1Ps6 -19) 유전자를 분리하기 위해 Pseudomonas sp. 6-19(KCTC11027BP)의 전체 DNA를 추출하고, phaC1Ps6-19 유전자 시퀀스 (송애진, Master's Thesis, Department of Chemical and Biomolecular Engineering, KAIST, 2004)에 기반한 서열번호 5과 6의 염기서열을 가지는 프라이머를 제작하고, PCR을 수행하여 phaC1Ps6 -19 유전자를 수득하였으며, phaC1Ps6 -19 유전자의 염기서열을 서열번호 7에 나타내었고, 이로부터 계산된 아미노산 서열을 서열번호 8에 나타내었다. Pseudomonas sp. To isolate PHA synthase (phaC1 Ps6 -19 ) gene from 6-19 (KCTC11027BP), Pseudomonas sp. Primer having the nucleotide sequences of SEQ ID NOs: 5 and 6 based on phaC1 Ps6-19 gene sequence (Song A-jin, Master's Thesis, Department of Chemical and Biomolecular Engineering, KAIST, 2004) production, and performing a PCR to obtain a phaC1 Ps6 was -19 gene, it exhibited a base sequence of the phaC1 Ps6 -19 gene is shown in SEQ ID NO: 7, exhibited an amino acid sequence calculated therefrom is shown in SEQ ID NO: 8.

서열번호 5: 5- GAG AGA CAA TCA AAT CAT GAG TAA CAA GAG TAA CG -3 SEQ ID NO: 5- GAG AGA CAA TCA AAT CAT GAG TAA CAA GAG TAA CG -3

서열번호 6: 5- CAC TCA TGC AAG CGT CAC CGT TCG TGC ACG TAC -3 SEQ ID NO 6: 5- CAC TCA TGC AAG CGT CAC CGT TCG TGC ACG TAC -3

상기 수득한 phaC1Ps6 -19 유전자를 pBluescript II(Stratagene Co., USA)의 BstBI/SbfI 인식부위에 삽입함으로써 pPs619C1 재조합 벡터를 제조하였다. BstBI/SbfI 인식부위가 각각 양끝에 하나씩만 포함된 phaC1Ps6 -19 합성효소 유전자 절편을 만들기 위해 우선 내재하고 있는 BstBI 위치를 SDM(site directed mutagenesis) 방법으로 아미노산의 변환 없이 제거하였고, BstBI/SbfI 인식부위를 첨가하기 위해 서열번호 9과 10, 서열번호 11와 12, 서열번호 13과 14의 염기서열을 가지는 프라이머를 이용하여 오버랩핑 PCR을 수행하였다. By inserting the thus obtained phaC1 Ps6 -19 gene into a BstBI / SbfI recognition site of pBluescript II (Stratagene Co., USA) to prepare a recombinant vector pPs619C1. In order to make a phaC1 Ps6 -19 synthase gene fragment containing only one BstBI / SbfI recognition site at each end, the BstBI position, which is inherent in the BstBI / SbfI recognition region, was first removed without conversion of amino acids by SDM (site directed mutagenesis) method. In order to add a site, overlapping PCR was performed using primers having the nucleotide sequences of SEQ ID NOs: 9 and 10, SEQ ID NOs: 11 and 12, and SEQ ID NOs: 13 and 14.

서열번호 9: 5- atg ccc gga gcc ggt tcg aa - 3 SEQ ID NO: 5- atg ccc gga gcc ggt tcg aa-3

서열번호 10: 5- CGT TAC TCT TGT TAC TCA TGA TTT GAT TGT CTC TC - 3 SEQ ID NO: 10: 5- CGT TAC TCT TGT TAC TCA TGA TTT GAT TGT CTC TC-3

서열번호 11: 5- GAG AGA CAA TCA AAT CAT GAG TAA CAA GAG TAA CG - 3 SEQ ID NO: 5- GAG AGA CAA TCA AAT CAT GAG TAA CAA GAG TAA CG-3

서열번호 12: 5- CAC TCA TGC AAG CGT CAC CGT TCG TGC ACG TAC - 3 SEQ ID NO: 12 5-CAC TCA TGC AAG CGT CAC CGT TCG TGC ACG TAC-3

서열번호 13: 5- GTA CGT GCA CGA ACG GTG ACG CTT GCA TGA GTG - 3 SEQ ID NO: 5- GTA CGT GCA CGA ACG GTG ACG CTT GCA TGA GTG-3

서열번호 14: 5- aac ggg agg gaa cct gca gg - 3 SEQ ID NO: 14 5- aac ggg agg gaa cct gca gg-3

아미노산 서열 배열분석을 통해 phaC1Ps6 -19 합성효소의 SCL(short-chain-length PHA) 합성활성에 영향을 미치는 아미노산 위치 3 곳(130, 325, 481)을 찾은 다음, 서열번호 15/16, 서열번호 17/18 및 서열번호 19/20의 프라이머를 이용하여, SDM 방법으로 phaC1Ps6 -19 합성효소의 아미노산 서열 중 E130D, S325T 및 Q481M가 변이된 변이체를 코딩하는 유전자를 함유하는 pPs619C1300를 제작하였다 (표 1). Locate the amino acid sequence of the phaC1 Ps6 SCL -19 synthase through the array analysis (short-chain-length PHA) on amino acid position affects three-synthesizing activity (130, 325, 481), and then, SEQ ID NO: 15/16, SEQ ID NO: number by using the primers of SEQ ID NOS: 17/18 and 19/20, was produced in the pPs619C1300 containing the gene for the amino acid sequence of the phaC1 Ps6 E130D, S325T and Q481M -19 synthase encoding the mutant variants to SDM method ( Table 1).

phaC1Ps6 -19 합성효소 변이체phaC1 Ps6 -19 synthase variant 재조합 벡터Recombinant vector 핵산 치환Nucleic Acid Substitution 아미노산 치환Amino acid substitutions 프라이머primer pPs619C1300pPs619C1300 GAA →GATGAA → GAT E130DE130D 서열번호 15/16SEQ ID NO: 15/16 AGC →ACCAGC → ACC S325TS325T 서열번호 17/18SEQ ID NO: 17/18 CAG →ATGCAG → ATG Q481MQ481M 서열번호 19/20SEQ ID NO: 19/20

서열번호 15: 5- atc aac ctc atg acc gat gcg atg gcg ccg acc- 3 SEQ ID NO: 15 5- atc aac ctc atg acc gat gcg atg gcg ccg acc-3

서열번호 16: 5- ggt cgg cgc cat cgc atc ggt cat gag gtt gat- 3 SEQ ID NO 16: 5- ggt cgg cgc cat cgc atc ggt cat gag gtt gat- 3

서열번호 17: 5- CTG ACC TTG CTG GTG ACC GTG CTT GAT ACC ACC- 3 SEQ ID NO: 17: 5- CTG ACC TTG CTG GTG ACC GTG CTT GAT ACC ACC- 3

서열번호 18: 5- GGT GGT ATC AAG CAC GGT CAC CAG CAA GGT CAG- 3 SEQ ID NO: 18- 5-GGT GGT ATC AAG CAC GGT CAC CAG CAA GGT CAG- 3

서열번호 19: 5- CGA GCA GCG GGC ATA TC A TGA GCA TCC TGA ACC CGC- 3 SEQ ID NO: 19: 5- CGA GCA GCG GGC ATA TC A TGA GCA TCC TGA ACC CGC- 3

서열번호 20: 5- GCG GGT TCA GGA TGC TCA TGA TAT GCC CGC TGC TCG- 3 SEQ ID NO: 20 5-GCG GGT TCA GGA TGC TCA TGA TAT GCC CGC TGC TCG- 3

상기 제작된 pPs619C1300벡터를 SbfI/NdeI으로 절단하여, 상기 클로닝한 CP-PCT 유전자를 SbfI/NdeI 인식부위에 삽입함으로써 pPs619C1300-CPPCT 재조합 벡터를 제작하였다 (도 2). The prepared pPs619C1300 vector was digested with Sbf I / Nde I, and the pPs619C1300-CPPCT recombinant vector was prepared by inserting the cloned CP-PCT gene into the Sbf I / Nde I recognition site (FIG. 2).

(2) pTacCpPctNCvEC 플라스미드의 제작(2) Construction of pTacCpPctNCvEC Plasmid

pTac99A (Park and Lee, J. Bacteriol. 185, 5391-5397, 2003)벡터를 SspI으로 절단하여 얻은 Tac 프로모터와 전사종결자(Transcription terminator)를 포함하는 유전자 단편을 SspI으로 절단한 pTrc99A (Pharmacia Biotech, Sweden)에 삽입하여 pTaclac 벡터를 제작하였다. Chromatium vinosum (DSMZ180) 염색체를 주형으로 하여 서열번호 21 및 서열번호 22의 프라이머를 이용하여 C. vinosum 의 phaEC를 증폭하였다. pTac99A (Park and Lee, J. Bacteriol. 185, 5391-5397, 2003) pTrc99A (Pharmacia Biotech) obtained by cutting a gene fragment containing a Tac promoter and transcription terminator obtained by cleaving a vector with Ssp I , Sweden) to create a pTaclac vector. Chromatium The phaEC of C. vinosum was amplified using primers of SEQ ID NO: 21 and SEQ ID NO: 22 using vinosum (DSMZ180) chromosome as a template.

서열번호 21: ggaaatc cat ATGACGATGTTCTCGCTCATGGCGSEQ ID NO: 21 ggaaatc cat ATGACGATGTTCTCGCTCATGGCG

서열번호 22: ggaaatc catatg atc cag ggc cac tat ctc caa ctg SEQ ID NO: 22 ggaaatc catatg atc cag ggc cac tat ctc caa ctg

증폭된 phaEC 유전자를 pTaclac 벡터를 NdeI으로 절단한 다음 삽입하여pTaclacNCvEC을 제작하였다. 또한 순차적으로 pPs619C1300-CPPCT을 EcoRI/XbaI으로 절단하여 수득한 pct 유전자를 EcoRI/XbaI으로 자른 pTaclacNCvEC에 삽입하여 pTacCpPctNCvEC를 제작하였다 (도 3). PTaclac vector was digested with Nde I and then amplified phaEC gene to prepare pTaclacNCvEC. In addition, the pct gene obtained by sequentially cutting pPs619C1300-CPPCT with EcoRI / XbaI was inserted into pTaclacNCvEC cut with EcoRI / XbaI to prepare pTacCpPctNCvEC (FIG. 3).

실시예Example 2: 3- 2: 3- 하이드록시프로피오네이트Hydroxypropionate -- 락테이트Lactate 공중합체의 제조 Preparation of Copolymer

실시예 1에서 제작한 pct 유전자와 PHA 유전자를 함유하는 재조합 플라스미드 pPs619C1300-CPPCT 및 pTacCpPctNCvEC를 각각 E. coli Top 10(Invitrogen)에 형질전환시켜, E.coli Top10/pPs619C1300-CPPCT 및 E. coli Top10/pTacCpPctNCvEC를 수득하였다.Example 1 a pct gene and the recombinant plasmid pPs619C1300-CPPCT and pTacCpPctNCvEC containing PHA produced by each gene was transformed into E. coli Top 10 (Invitrogen), E.coli Top10 / pPs619C1300-CPPCT and E. coli Top10 / pTacCpPctNCvEC was obtained.

상기 두 종의 형질전환체를 하기와 같이 2단계 배양하여, 3-하이드록시부티레이트-3-하이드록시프로피오네이트-락테이트 삼중합체를 수득하였다. 먼저 상기 형질전환 재조합 대장균 E. coli Top10/pPs619C1300-CPPCT 및 E. coli Top10/pTacCpPctNCvEC을 각각 100 mg/L의 앰피실린(ampicillin)이 함유되어 있는 100 mL의 LB 배지(BactoTM Triptone(BD) 10 g/L, BactoTM yeast extract(BD) 5 g/L; NaCl(amresco) 10 g/L)에서 24 시간 배양한 후 4℃, 1000g에서 15분간 원심분리 하여 균체를 회수하였다. The two kinds of transformants are cultured in two steps as follows. 3-hydroxybutyrate-3-hydroxypropionate-lactate terpolymer was obtained. First, 100 mL of LB medium (Bacto TM Triptone (BD) 10 containing 100 mg / L of ampicillin, respectively, was used for transforming recombinant E. coli E. coli Top10 / pPs619C1300-CPPCT and E. coli Top10 / pTacCpPctNCvEC. After incubation for 24 hours in g / L, Bacto TM yeast extract (BD) 5 g / L; NaCl (amresco) 10 g / L), the cells were recovered by centrifugation for 15 minutes at 4 ℃, 1000g.

이때 E. coli Top10/pTacCpPctNCvEC의 경우 600nm에서의 흡광도 (OD600)가 약 0.6에 이르렀을 때 IPTG를 1 mM이 되도록 첨가해 주었다.In the case of E. coli Top10 / pTacCpPctNCvEC, when the absorbance at 600 nm (OD 600 ) reached about 0.6, IPTG was added to 1 mM.

회수한 균체를 2 g/L의 3-하이드록시프로피오네이트(3-HP), 1g/L의 3-하이드록시부티레이트(3-HB) 및 100 mg/L의 앰피실린이 추가로 함유된 MR 배지(1L 당 Glucose 10 g, KH2PO4 6.67 g, (NH4)2HPO4 4 g, MgSO4·7H2O 0.8 g, citric acid 0.8 g 및 trace metal solution 5 mL; Trace metal solution의 조성:1 L 당 5M HCl 5 mL, FeSO4·7H2O 10 g, CaCl2 2 g, ZnSO4·7H2O 2.2 g, MnSO4·4H2O 0.5 g, CuSO4·5H2O 1 g, (NH4)6Mo7O2·4H2O 0.1 g, 및 Na2B4O2·10H2O 0.02 g)에서 3일 동안 혐기배양하였다. Recovered cells were MR containing 2 g / L 3-hydroxypropionate (3-HP), 1 g / L 3-hydroxybutyrate (3-HB) and 100 mg / L ampicillin. Medium (10 g Glucose per 1 L, 6.67 g KH 2 PO 4 , (NH 4 ) 2 HPO 4 4 g, MgSO 4 7H 2 O 0.8 g, 0.8 g citric acid and 5 mL trace metal solution; composition of trace metal solution : 5 mL of 5M HCl, 1 g of FeSO 4 .7H 2 O, 10 g of CaCl 2 , 2.2 g of ZnSO 4 , 7H 2 O, 0.5 g of MnSO 4 · 4H 2 O, 1 g of CuSO 4 · 5H 2 O, 0.1 g of (NH 4 ) 6 Mo 7 O 2 .4H 2 O, and 0.02 g of Na 2 B 4 O 2 .10H 2 O) for 3 days.

상기 배양액을 4℃, 1000g에서 15분간 원심분리 하여 균체를 회수하고 충분한 양의 증류수로 4회 씻어준 후 80℃에서 12시간 건조 하였다. 습기가 완전히 제거된 균체를 정량한 후 100℃에서 클로로포름을 용매로 사용하여 황산 촉매 하에서 메탄올과 반응시켜 주었다. 이를 상온에서 클로로포름의 절반에 해당하는 부피의 증류수를 첨가하여 혼합한 후 두개의 층으로 분리될 때까지 정치시켰다. 두 개의 층 중에서 메틸화된 고분자의 단량체들이 녹아 있는 클로로포름층을 채취하여 가스크로마토그래피로 고분자의 성분을 분석하였다. 내부 표준물질로는 벤조에이트(benzoate)를 사용하였다. The culture solution was centrifuged at 4 ° C. and 1000 g for 15 minutes to recover the cells, washed four times with a sufficient amount of distilled water, and dried at 80 ° C. for 12 hours. After quantifying the cells completely removed moisture was reacted with methanol under sulfuric acid catalyst using chloroform as a solvent at 100 ℃. This was mixed by adding distilled water equal to half the volume of chloroform at room temperature and allowed to stand until it was separated into two layers. The chloroform layer in which the monomers of the methylated polymer were dissolved in two layers was taken and analyzed by gas chromatography. As an internal standard, benzoate was used.

분석 결과, 도 4 및 도 5에 나타난 바와 같이, E. coli Top10/pPs619C1300-CPPCT 및 E.coli Top10/pTacCpPctNCvEC 균체 모두에서, 메틸-3-하이드록시프로피오네이트(metyl-3-hydroxypropionate), 메틸-3-하이드록시부티레이트(metyl-3-hydroxybutyrate) 및 메틸-락테이트(methyl-lactate)가 검출되어 재조합 대장균에 의해 3-하이드록시부티레이트-3-하이드록시프로피오네이트-락테이트 삼중합체[poly(3-hydroxybutyrate-co-hydroxypropionate-co-lactate)]가 생성되었음을 확인할 수 있었다.As shown in FIG. 4 and FIG. 5, methyl-3-hydroxypropionate, methyl in both E. coli Top10 / pPs619C1300-CPPCT and E. coli Top10 / pTacCpPctNCvEC cells. 3-hydroxybutyrate and methyl-lactate were detected, and 3-hydroxybutyrate-3-hydroxypropionate-lactate terpolymers were detected by recombinant E. coli [poly (3-hydroxybutyrate-co-hydroxypropionate-co-lactate)] was confirmed to be produced.

이상에서 상세히 설명하고 입증하였듯이, 본 발명은 신규 3-하이드록시부티레이트-3-하이드록시프로피오네이트-락테이트 삼중합체[poly(3-hydroxybutyrate-co-hydroxypropionate-co-lactate)]를 제공하는 효과가 있으며, 락테이트(lactate)를 락틸-CoA(lactyl-CoA)로 전환하고 3-하이드록시알카노에트(3-hydroxyalkanoate)를 3-하이드록시알카노일-CoA(3-hydroxyalkanoyl-CoA)로 전환하는 효소의 유전자 및 폴리하이드록시알카노에트(polyhydroxyalkanoate:PHA) 합성효소 유전자를 동시에 가지는 세포 또는 식물을 배양 또는 재배하는 것을 특징으로 하는 3-하이드록시부티레이트-3-하이드록시프로피오네이트-락테이트 삼중합체[poly(3-hydroxybutyrate-co-hydroxypropionate-co-lactate)]의 제조방법을 제공하는 효과 가 있다. 본 발명에 따른 신규 3-하이드록시부티레이트-3-하이드록시프로피오네이트-락테이트 삼중합체[poly(3-hydroxybutyrate-co-hydroxypropionate-co-lactate)]는 생분해성 고분자로서 종래 합성 플라스틱의 용도를 대체할 수 있으며, 의료용으로도 사용이 가능하다.As described and demonstrated in detail above, the present invention provides a novel 3-hydroxybutyrate-3-hydroxypropionate-lactate terpolymer [poly (3-hydroxybutyrate-co-hydroxypropionate-co-lactate)] Convert lactate to lactyl-CoA and 3-hydroxyalkanoate to 3-hydroxyalkanoyl-CoA 3-hydroxybutyrate-3-hydroxypropionate-lactate, characterized by culturing or cultivating cells or plants having both an enzyme gene and a polyhydroxyalkanoate (PHA) synthase gene. It is effective to provide a method for preparing a terpolymer (poly (3-hydroxybutyrate-co-hydroxypropionate-co-lactate)). The novel 3-hydroxybutyrate-3-hydroxypropionate-lactate terpolymer [poly (3-hydroxybutyrate-co-hydroxypropionate-co-lactate)] according to the present invention is a biodegradable polymer that can be used for conventional synthetic plastics. It can be replaced and used for medical purposes.

이상으로 본 발명 내용의 특정한 부분을 상세히 기술하였는 바, 당업계의 통상의 지식을 가진 자에게 있어서, 이러한 구체적 기술은 단지 바람직한 실시예일뿐이며, 이에 의해 본 발명의 범위가 제한되는 것이 아닌 점은 명백할 것이다. 따라서, 본 발명의 실질적인 범위는 첨부된 청구항들과 그것들의 등가물에 의하여 정의된다고 할 것이다.  본 발명의 단순한 변형 내지 변경은 이 분야의 통상의 지식을 가진 자에 의하여 용이하게 이용될 수 있으며, 이러한 변형이나 변경은 모두 본 발명의 영역에 포함되는 것으로 볼 수 있다. As described above in detail specific parts of the present invention, it is apparent to those skilled in the art that such specific descriptions are merely preferred embodiments, and thus the scope of the present invention is not limited thereto. something to do. Thus, the substantial scope of the present invention will be defined by the appended claims and their equivalents. Simple modifications and variations of the present invention can be readily used by those skilled in the art, and all such variations or modifications can be considered to be included within the scope of the present invention.

<110> LG CHEM, LTD Korea Advanced Institute of Science and Technology <120> Novel Copolymer of [poly(3-hydroxybutyrate-co-hydroxypropionate-co-lactate)] and Method for Preparing the Same <130> P06-B231 <160> 22 <170> KopatentIn 1.71 <210> 1 <211> 39 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 1 ggaattcatg agaaaggttc ccattattac cgcagatga 39 <210> 2 <211> 46 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 2 gctctagatt aggacttcat ttccttcaga cccattaagc cttctg 46 <210> 3 <211> 32 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 3 aggcctgcag gcggataaca atttcacaca gg 32 <210> 4 <211> 31 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 4 gcccatatgt ctagattagg acttcatttc c 31 <210> 5 <211> 35 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 5 gagagacaat caaatcatga gtaacaagag taacg 35 <210> 6 <211> 33 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 6 cactcatgca agcgtcaccg ttcgtgcacg tac 33 <210> 7 <211> 1677 <212> DNA <213> Pseudomonas sp. 6-19(KCTC11027BP) <400> 7 atgagtaaca agagtaacga tgagttgaag tatcaagcct ctgaaaacac cttggggctt 60 aatcctgtcg ttgggctgcg tggaaaggat ctactggctt ctgctcgaat ggtgcttagg 120 caggccatca agcaaccggt gcacagcgtc aaacatgtcg cgcactttgg tcttgaactc 180 aagaacgtac tgctgggtaa atccgggctg caaccgacca gcgatgaccg tcgcttcgcc 240 gatccggcct ggagccagaa cccgctctat aaacgttatt tgcaaaccta cctggcgtgg 300 cgcaaggaac tccacgactg gatcgatgaa agtaacctcg cccccaagga tgtggcgcgt 360 gggcacttcg tgatcaacct catgaccgaa gcgatggcgc cgaccaacac cgcggccaac 420 ccggcggcag tcaaacgctt ttttgaaacc ggtggcaaaa gcctgctcga cggcctctcg 480 cacctggcca aggatctggt acacaacggc ggcatgccga gccaggtcaa catgggtgca 540 ttcgaggtcg gcaagagcct gggcgtgacc gaaggcgcgg tggtgtttcg caacgatgtg 600 ctggaactga tccagtacaa gccgaccacc gagcaggtat acgaacgccc gctgctggtg 660 gtgccgccgc agatcaacaa gttctacgtt ttcgacctga gcccggacaa gagcctggcg 720 cggttctgcc tgcgcaacaa cgtgcaaacg ttcatcgtca gctggcgaaa tcccaccaag 780 gaacagcgag agtggggcct gtcgacctac atcgaagccc tcaaggaagc ggttgacgtc 840 gttaccgcga tcaccggcag caaagacgtg aacatgctcg gggcctgctc cggcggcatc 900 acttgcactg cgctgctggg ccattacgcg gcgattggcg aaaacaaggt caacgccctg 960 accttgctgg tgagcgtgct tgataccacc ctcgacagcg acgtcgccct gttcgtcaat 1020 gaacagaccc ttgaagccgc caagcgccac tcgtaccagg ccggcgtact ggaaggccgc 1080 gacatggcga aggtcttcgc ctggatgcgc cccaacgatc tgatctggaa ctactgggtc 1140 aacaattacc tgctaggcaa cgaaccgccg gtgttcgaca tcctgttctg gaacaacgac 1200 accacacggt tgcccgcggc gttccacggc gacctgatcg aactgttcaa aaataaccca 1260 ctgattcgcc cgaatgcact ggaagtgtgc ggcaccccca tcgacctcaa gcaggtgacg 1320 gccgacatct tttccctggc cggcaccaac gaccacatca ccccgtggaa gtcctgctac 1380 aagtcggcgc aactgtttgg cggcaacgtt gaattcgtgc tgtcgagcag cgggcatatc 1440 cagagcatcc tgaacccgcc gggcaatccg aaatcgcgct acatgaccag caccgaagtg 1500 gcggaaaatg ccgatgaatg gcaagcgaat gccaccaagc atacagattc ctggtggctg 1560 cactggcagg cctggcaggc ccaacgctcg ggcgagctga aaaagtcccc gacaaaactg 1620 ggcagcaagg cgtatccggc aggtgaagcg gcgccaggca cgtacgtgca cgaacgg 1677 <210> 8 <211> 559 <212> PRT <213> Pseudomonas sp.6-19(KCTC11027BP) <400> 8 Met Ser Asn Lys Ser Asn Asp Glu Leu Lys Tyr Gln Ala Ser Glu Asn 1 5 10 15 Thr Leu Gly Leu Asn Pro Val Val Gly Leu Arg Gly Lys Asp Leu Leu 20 25 30 Ala Ser Ala Arg Met Val Leu Arg Gln Ala Ile Lys Gln Pro Val His 35 40 45 Ser Val Lys His Val Ala His Phe Gly Leu Glu Leu Lys Asn Val Leu 50 55 60 Leu Gly Lys Ser Gly Leu Gln Pro Thr Ser Asp Asp Arg Arg Phe Ala 65 70 75 80 Asp Pro Ala Trp Ser Gln Asn Pro Leu Tyr Lys Arg Tyr Leu Gln Thr 85 90 95 Tyr Leu Ala Trp Arg Lys Glu Leu His Asp Trp Ile Asp Glu Ser Asn 100 105 110 Leu Ala Pro Lys Asp Val Ala Arg Gly His Phe Val Ile Asn Leu Met 115 120 125 Thr Glu Ala Met Ala Pro Thr Asn Thr Ala Ala Asn Pro Ala Ala Val 130 135 140 Lys Arg Phe Phe Glu Thr Gly Gly Lys Ser Leu Leu Asp Gly Leu Ser 145 150 155 160 His Leu Ala Lys Asp Leu Val His Asn Gly Gly Met Pro Ser Gln Val 165 170 175 Asn Met Gly Ala Phe Glu Val Gly Lys Ser Leu Gly Val Thr Glu Gly 180 185 190 Ala Val Val Phe Arg Asn Asp Val Leu Glu Leu Ile Gln Tyr Lys Pro 195 200 205 Thr Thr Glu Gln Val Tyr Glu Arg Pro Leu Leu Val Val Pro Pro Gln 210 215 220 Ile Asn Lys Phe Tyr Val Phe Asp Leu Ser Pro Asp Lys Ser Leu Ala 225 230 235 240 Arg Phe Cys Leu Arg Asn Asn Val Gln Thr Phe Ile Val Ser Trp Arg 245 250 255 Asn Pro Thr Lys Glu Gln Arg Glu Trp Gly Leu Ser Thr Tyr Ile Glu 260 265 270 Ala Leu Lys Glu Ala Val Asp Val Val Thr Ala Ile Thr Gly Ser Lys 275 280 285 Asp Val Asn Met Leu Gly Ala Cys Ser Gly Gly Ile Thr Cys Thr Ala 290 295 300 Leu Leu Gly His Tyr Ala Ala Ile Gly Glu Asn Lys Val Asn Ala Leu 305 310 315 320 Thr Leu Leu Val Ser Val Leu Asp Thr Thr Leu Asp Ser Asp Val Ala 325 330 335 Leu Phe Val Asn Glu Gln Thr Leu Glu Ala Ala Lys Arg His Ser Tyr 340 345 350 Gln Ala Gly Val Leu Glu Gly Arg Asp Met Ala Lys Val Phe Ala Trp 355 360 365 Met Arg Pro Asn Asp Leu Ile Trp Asn Tyr Trp Val Asn Asn Tyr Leu 370 375 380 Leu Gly Asn Glu Pro Pro Val Phe Asp Ile Leu Phe Trp Asn Asn Asp 385 390 395 400 Thr Thr Arg Leu Pro Ala Ala Phe His Gly Asp Leu Ile Glu Leu Phe 405 410 415 Lys Asn Asn Pro Leu Ile Arg Pro Asn Ala Leu Glu Val Cys Gly Thr 420 425 430 Pro Ile Asp Leu Lys Gln Val Thr Ala Asp Ile Phe Ser Leu Ala Gly 435 440 445 Thr Asn Asp His Ile Thr Pro Trp Lys Ser Cys Tyr Lys Ser Ala Gln 450 455 460 Leu Phe Gly Gly Asn Val Glu Phe Val Leu Ser Ser Ser Gly His Ile 465 470 475 480 Gln Ser Ile Leu Asn Pro Pro Gly Asn Pro Lys Ser Arg Tyr Met Thr 485 490 495 Ser Thr Glu Val Ala Glu Asn Ala Asp Glu Trp Gln Ala Asn Ala Thr 500 505 510 Lys His Thr Asp Ser Trp Trp Leu His Trp Gln Ala Trp Gln Ala Gln 515 520 525 Arg Ser Gly Glu Leu Lys Lys Ser Pro Thr Lys Leu Gly Ser Lys Ala 530 535 540 Tyr Pro Ala Gly Glu Ala Ala Pro Gly Thr Tyr Val His Glu Arg 545 550 555 <210> 9 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 9 atgcccggag ccggttcgaa 20 <210> 10 <211> 35 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 10 cgttactctt gttactcatg atttgattgt ctctc 35 <210> 11 <211> 35 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 11 gagagacaat caaatcatga gtaacaagag taacg 35 <210> 12 <211> 33 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 12 cactcatgca agcgtcaccg ttcgtgcacg tac 33 <210> 13 <211> 33 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 13 gtacgtgcac gaacggtgac gcttgcatga gtg 33 <210> 14 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 14 aacgggaggg aacctgcagg 20 <210> 15 <211> 33 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 15 atcaacctca tgaccgatgc gatggcgccg acc 33 <210> 16 <211> 33 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 16 ggtcggcgcc atcgcatcgg tcatgaggtt gat 33 <210> 17 <211> 33 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 17 ctgaccttgc tggtgaccgt gcttgatacc acc 33 <210> 18 <211> 33 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 18 ggtggtatca agcacggtca ccagcaaggt cag 33 <210> 19 <211> 36 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 19 cgagcagcgg gcatatcatg agcatcctga acccgc 36 <210> 20 <211> 36 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 20 gcgggttcag gatgctcatg atatgcccgc tgctcg 36 <210> 21 <211> 34 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 21 ggaaatccat atgacgatgt tctcgctcat ggcg 34 <210> 22 <211> 37 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 22 ggaaatccat atgatccagg gccactatct ccaactg 37 <110> LG CHEM, LTD          Korea Advanced Institute of Science and Technology <120> Novel Copolymer of          poly (3-hydroxybutyrate-co-hydroxypropionate-co-lactate) and          Method for Preparing the Same <130> P06-B231 <160> 22 <170> KopatentIn 1.71 <210> 1 <211> 39 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 1 ggaattcatg agaaaggttc ccattattac cgcagatga 39 <210> 2 <211> 46 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 2 gctctagatt aggacttcat ttccttcaga cccattaagc cttctg 46 <210> 3 <211> 32 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 3 aggcctgcag gcggataaca atttcacaca gg 32 <210> 4 <211> 31 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 4 gcccatatgt ctagattagg acttcatttc c 31 <210> 5 <211> 35 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 5 gagagacaat caaatcatga gtaacaagag taacg 35 <210> 6 <211> 33 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 6 cactcatgca agcgtcaccg ttcgtgcacg tac 33 <210> 7 <211> 1677 <212> DNA Pseudomonas sp. 6-19 (KCTC11027BP) <400> 7 atgagtaaca agagtaacga tgagttgaag tatcaagcct ctgaaaacac cttggggctt 60 aatcctgtcg ttgggctgcg tggaaaggat ctactggctt ctgctcgaat ggtgcttagg 120 caggccatca agcaaccggt gcacagcgtc aaacatgtcg cgcactttgg tcttgaactc 180 aagaacgtac tgctgggtaa atccgggctg caaccgacca gcgatgaccg tcgcttcgcc 240 gatccggcct ggagccagaa cccgctctat aaacgttatt tgcaaaccta cctggcgtgg 300 cgcaaggaac tccacgactg gatcgatgaa agtaacctcg cccccaagga tgtggcgcgt 360 gggcacttcg tgatcaacct catgaccgaa gcgatggcgc cgaccaacac cgcggccaac 420 ccggcggcag tcaaacgctt ttttgaaacc ggtggcaaaa gcctgctcga cggcctctcg 480 cacctggcca aggatctggt acacaacggc ggcatgccga gccaggtcaa catgggtgca 540 ttcgaggtcg gcaagagcct gggcgtgacc gaaggcgcgg tggtgtttcg caacgatgtg 600 ctggaactga tccagtacaa gccgaccacc gagcaggtat acgaacgccc gctgctggtg 660 gtgccgccgc agatcaacaa gttctacgtt ttcgacctga gcccggacaa gagcctggcg 720 cggttctgcc tgcgcaacaa cgtgcaaacg ttcatcgtca gctggcgaaa tcccaccaag 780 gaacagcgag agtggggcct gtcgacctac atcgaagccc tcaaggaagc ggttgacgtc 840 gttaccgcga tcaccggcag caaagacgtg aacatgctcg gggcctgctc cggcggcatc 900 acttgcactg cgctgctggg ccattacgcg gcgattggcg aaaacaaggt caacgccctg 960 accttgctgg tgagcgtgct tgataccacc ctcgacagcg acgtcgccct gttcgtcaat 1020 gaacagaccc ttgaagccgc caagcgccac tcgtaccagg ccggcgtact ggaaggccgc 1080 gacatggcga aggtcttcgc ctggatgcgc cccaacgatc tgatctggaa ctactgggtc 1140 aacaattacc tgctaggcaa cgaaccgccg gtgttcgaca tcctgttctg gaacaacgac 1200 accacacggt tgcccgcggc gttccacggc gacctgatcg aactgttcaa aaataaccca 1260 ctgattcgcc cgaatgcact ggaagtgtgc ggcaccccca tcgacctcaa gcaggtgacg 1320 gccgacatct tttccctggc cggcaccaac gaccacatca ccccgtggaa gtcctgctac 1380 aagtcggcgc aactgtttgg cggcaacgtt gaattcgtgc tgtcgagcag cgggcatatc 1440 cagagcatcc tgaacccgcc gggcaatccg aaatcgcgct acatgaccag caccgaagtg 1500 gcggaaaatg ccgatgaatg gcaagcgaat gccaccaagc atacagattc ctggtggctg 1560 cactggcagg cctggcaggc ccaacgctcg ggcgagctga aaaagtcccc gacaaaactg 1620 ggcagcaagg cgtatccggc aggtgaagcg gcgccaggca cgtacgtgca cgaacgg 1677 <210> 8 <211> 559 <212> PRT Pseudomonas sp. 6-19 (KCTC11027BP) <400> 8 Met Ser Asn Lys Ser Asn Asp Glu Leu Lys Tyr Gln Ala Ser Glu Asn   1 5 10 15 Thr Leu Gly Leu Asn Pro Val Val Gly Leu Arg Gly Lys Asp Leu Leu              20 25 30 Ala Ser Ala Arg Met Val Leu Arg Gln Ala Ile Lys Gln Pro Val His          35 40 45 Ser Val Lys His Val Ala His Phe Gly Leu Glu Leu Lys Asn Val Leu      50 55 60 Leu Gly Lys Ser Gly Leu Gln Pro Thr Ser Asp Asp Arg Arg Phe Ala  65 70 75 80 Asp Pro Ala Trp Ser Gln Asn Pro Leu Tyr Lys Arg Tyr Leu Gln Thr                  85 90 95 Tyr Leu Ala Trp Arg Lys Glu Leu His Asp Trp Ile Asp Glu Ser Asn             100 105 110 Leu Ala Pro Lys Asp Val Ala Arg Gly His Phe Val Ile Asn Leu Met         115 120 125 Thr Glu Ala Met Ala Pro Thr Asn Thr Ala Ala Asn Pro Ala Ala Val     130 135 140 Lys Arg Phe Phe Glu Thr Gly Gly Lys Ser Leu Leu Asp Gly Leu Ser 145 150 155 160 His Leu Ala Lys Asp Leu Val His Asn Gly Gly Met Pro Ser Gln Val                 165 170 175 Asn Met Gly Ala Phe Glu Val Gly Lys Ser Leu Gly Val Thr Glu Gly             180 185 190 Ala Val Val Phe Arg Asn Asp Val Leu Glu Leu Ile Gln Tyr Lys Pro         195 200 205 Thr Thr Glu Gln Val Tyr Glu Arg Pro Leu Leu Val Val Pro Pro Gln     210 215 220 Ile Asn Lys Phe Tyr Val Phe Asp Leu Ser Pro Asp Lys Ser Leu Ala 225 230 235 240 Arg Phe Cys Leu Arg Asn Asn Val Gln Thr Phe Ile Val Ser Trp Arg                 245 250 255 Asn Pro Thr Lys Glu Gln Arg Glu Trp Gly Leu Ser Thr Tyr Ile Glu             260 265 270 Ala Leu Lys Glu Ala Val Asp Val Val Thr Ala Ile Thr Gly Ser Lys         275 280 285 Asp Val Asn Met Leu Gly Ala Cys Ser Gly Gly Ile Thr Cys Thr Ala     290 295 300 Leu Leu Gly His Tyr Ala Ala Ile Gly Glu Asn Lys Val Asn Ala Leu 305 310 315 320 Thr Leu Leu Val Ser Val Leu Asp Thr Thr Leu Asp Ser Asp Val Ala                 325 330 335 Leu Phe Val Asn Glu Gln Thr Leu Glu Ala Ala Lys Arg His Ser Tyr             340 345 350 Gln Ala Gly Val Leu Glu Gly Arg Asp Met Ala Lys Val Phe Ala Trp         355 360 365 Met Arg Pro Asn Asp Leu Ile Trp Asn Tyr Trp Val Asn Asn Tyr Leu     370 375 380 Leu Gly Asn Glu Pro Pro Val Phe Asp Ile Leu Phe Trp Asn Asn Asp 385 390 395 400 Thr Thr Arg Leu Pro Ala Ala Phe His Gly Asp Leu Ile Glu Leu Phe                 405 410 415 Lys Asn Asn Pro Leu Ile Arg Pro Asn Ala Leu Glu Val Cys Gly Thr             420 425 430 Pro Ile Asp Leu Lys Gln Val Thr Ala Asp Ile Phe Ser Leu Ala Gly         435 440 445 Thr Asn Asp His Ile Thr Pro Trp Lys Ser Cys Tyr Lys Ser Ala Gln     450 455 460 Leu Phe Gly Gly Asn Val Glu Phe Val Leu Ser Ser Ser Gly His Ile 465 470 475 480 Gln Ser Ile Leu Asn Pro Pro Gly Asn Pro Lys Ser Arg Tyr Met Thr                 485 490 495 Ser Thr Glu Val Ala Glu Asn Ala Asp Glu Trp Gln Ala Asn Ala Thr             500 505 510 Lys His Thr Asp Ser Trp Trp Leu His Trp Gln Ala Trp Gln Ala Gln         515 520 525 Arg Ser Gly Glu Leu Lys Lys Ser Pro Thr Lys Leu Gly Ser Lys Ala     530 535 540 Tyr Pro Ala Gly Glu Ala Ala Pro Gly Thr Tyr Val His Glu Arg 545 550 555 <210> 9 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 9 atgcccggag ccggttcgaa 20 <210> 10 <211> 35 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 10 cgttactctt gttactcatg atttgattgt ctctc 35 <210> 11 <211> 35 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 11 gagagacaat caaatcatga gtaacaagag taacg 35 <210> 12 <211> 33 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 12 cactcatgca agcgtcaccg ttcgtgcacg tac 33 <210> 13 <211> 33 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 13 gtacgtgcac gaacggtgac gcttgcatga gtg 33 <210> 14 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 14 aacgggaggg aacctgcagg 20 <210> 15 <211> 33 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 15 atcaacctca tgaccgatgc gatggcgccg acc 33 <210> 16 <211> 33 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 16 ggtcggcgcc atcgcatcgg tcatgaggtt gat 33 <210> 17 <211> 33 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 17 ctgaccttgc tggtgaccgt gcttgatacc acc 33 <210> 18 <211> 33 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 18 ggtggtatca agcacggtca ccagcaaggt cag 33 <210> 19 <211> 36 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 19 cgagcagcgg gcatatcatg agcatcctga acccgc 36 <210> 20 <211> 36 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 20 gcgggttcag gatgctcatg atatgcccgc tgctcg 36 <210> 21 <211> 34 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 21 ggaaatccat atgacgatgt tctcgctcat ggcg 34 <210> 22 <211> 37 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 22 ggaaatccat atgatccagg gccactatct ccaactg 37  

Claims (11)

락테이트와 3-하이드록시프로피오네이트 및 3-하이드록시부티레이트를 반복단위로 함유하는 3-하이드록시부티레이트-3-하이드록시프로피오네이트-락테이트 삼중합체 [poly(3-hydroxybutyrate-co-hydroxypropionate-co-lactate)].3-hydroxybutyrate-3-hydroxypropionate-lactate terpolymers containing lactate, 3-hydroxypropionate and 3-hydroxybutyrate as repeat units [poly (3-hydroxybutyrate-co-hydroxypropionate -co-lactate)]. 락테이트(lactate)를 락틸-CoA(lactyl-CoA)로 전환하고 3-하이드록시알카노에트(3-hydroxyalkanoate)를 3-하이드록시알카노일-CoA(3-hydroxyalkanoyl-CoA)로 전환하는 효소의 유전자 및 폴리하이드록시알카노에트(polyhydroxyalkanoate:PHA) 합성효소 유전자를 동시에 가지는 세포 또는 식물을 배양 또는 재배하는 것을 특징으로 하는 3-하이드록시부티레이트-3-하이드록시프로피오네이트-락테이트 삼중합체 [poly(3-hydroxybutyrate-co-hydroxypropionate-co-lactate)] 의 제조방법.Of enzymes that convert lactate to lactyl-CoA and 3-hydroxyalkanoate to 3-hydroxyalkanoyl-CoA 3-hydroxybutyrate-3-hydroxypropionate-lactate terpolymer, characterized by culturing or culturing cells or plants having a gene and a polyhydroxyalkanoate (PHA) synthase gene simultaneously [ poly (3-hydroxybutyrate-co-hydroxypropionate-co-lactate)]. 제2항에 있어서, 세포 또는 식물은 상기 두 유전자를 모두 가지지 않는 세포 또는 식물을 락테이트(lactate)를 락틸-CoA(lactyl-CoA)로 전환하고 3-하이드록시알카노에트(3-hydroxyalkanoate)를 3-하이드록시알카노일-CoA(3-hydroxyalkanoyl-CoA)로 전환하는 효소의 유전자와 lactyl-CoA를 기질로 사용하는 PHA 합성효소의 유전자로 형질전환하여 수득되는 것임을 특징으로 하는 방법.The method of claim 2, wherein the cell or plant converts lactate to lactyl-CoA and 3-hydroxyalkanoate that does not have both genes. It is obtained by transforming the gene of the enzyme to convert to 3-hydroxyalkanoyl-CoA (3-hydroxyalkanoyl-CoA) and the gene of PHA synthase using lactyl-CoA as a substrate. 제2항에 있어서, 세포 또는 식물은 lactyl-CoA를 기질로 사용하는 PHA 합성효소의 유전자를 가지는 세포 또는 식물을 락테이트(lactate)를 락틸-CoA(lactyl-CoA)로 전환하고 3-하이드록시알카노에트(3-hydroxyalkanoate)를 3-하이드록시알카노일-CoA(3-hydroxyalkanoyl-CoA)로 전환하는 효소의 유전자로 형질전환하여 수득되는 것임을 특징으로 하는 방법.The method according to claim 2, wherein the cell or plant converts lactate to lactyl-CoA and 3-hydroxy to a cell or plant having a gene of PHA synthase using lactyl-CoA as a substrate. And a method obtained by transforming alkanoate (3-hydroxyalkanoate) with a gene of an enzyme that converts 3-hydroxyalkanoyl-CoA (3-hydroxyalkanoyl-CoA). 제2항에 있어서, 세포 또는 식물은 락테이트(lactate)를 락틸-CoA(lactyl-CoA)로 전환하고 3-하이드록시알카노에트(3-hydroxyalkanoate)를 3-하이드록시알카노일-CoA(3-hydroxyalkanoyl-CoA)로 전환하는 효소의 유전자를 가지는 세포 또는 식물을 lactyl-CoA를 기질로 사용하는 PHA 합성효소의 유전자로 형질전환하여 수득되는 것임을 특징으로 하는 방법.The method of claim 2, wherein the cell or plant converts lactate to lactyl-CoA and 3-hydroxyalkanoate to 3-hydroxyalkanoyl-CoA (3). -hydroxyalkanoyl-CoA) is obtained by transforming a cell or plant having the gene of the enzyme converting with a gene of PHA synthase using lactyl-CoA as a substrate. 제2항에 있어서, 상기 락테이트(lactate)를 락틸-CoA(lactyl-CoA)로 전환하고 3-하이드록시알카노에트(3-hydroxyalkanoate)를 3-하이드록시알카노일-CoA(3-hydroxyalkanoyl-CoA)로 전환하는 효소의 유전자는 프로피오닐-CoA 트랜스퍼라아제 유전자(pct)인 것을 특징으로 하는 방법.The method of claim 2, wherein the lactate is converted to lactyl-CoA and 3-hydroxyalkanoate is converted into 3-hydroxyalkanoyl-CoA. The gene of the enzyme converting to CoA) is propionyl-CoA transferase gene ( pct ). 제2항에 있어서, 폴리하이드록시알카노에트(polyhydroxyalkanoate:PHA) 합성효소 유전자는 슈도모나스 속(Pseudomonas sp.) 6-19 유래의 phaC1ps6 -19인 것을 특징으로 하는 방법.The method of claim 2, wherein the polyhydroxyalkanoate (PHA) synthase gene is phaC1 ps6 -19 from Pseudomonas sp. 6-19. 제2항에 있어서, 폴리하이드록시알카노에트(polyhydroxyalkanoate:PHA) 합성효소 유전자는 서열번호 7의 아미노산 서열에서 E130D, S325T 및 Q481M가 변이된 아미노산 서열을 코딩하는 유전자인 것을 특징으로 하는 방법.The method of claim 2, wherein the polyhydroxyalkanoate (PHA) synthase gene is a gene encoding an amino acid sequence of which E130D, S325T and Q481M are mutated in the amino acid sequence of SEQ ID NO. 7. 제2항에 있어서, 세포는 미생물인 것을 특징으로 하는 방법.The method of claim 2, wherein the cell is a microorganism. 제9항에 있어서, 미생물은 대장균인 것을 특징으로 하는 방법.10. The method of claim 9, wherein the microorganism is Escherichia coli. 제2항에 있어서, 배양 또는 재배는 3-하이드록시프로피오네이트(3-HP) 및 3- 하이드록시부티레이트(3-HB)를 함유하는 환경에서 수행되는 것 특징으로 하는 방법.The method of claim 2, wherein the culturing or cultivation is performed in an environment containing 3-hydroxypropionate (3-HP) and 3-hydroxybutyrate (3-HB).
KR1020060116233A 2006-11-21 2006-11-23 Novel Copolymer of [poly3-hydroxybutyrate-co-hydroxypropionate-co-lactate] and Method for Preparing the Same KR100957776B1 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
KR1020060116233A KR100957776B1 (en) 2006-11-23 2006-11-23 Novel Copolymer of [poly3-hydroxybutyrate-co-hydroxypropionate-co-lactate] and Method for Preparing the Same
PCT/KR2007/005853 WO2008062996A1 (en) 2006-11-21 2007-11-21 Copolymer containing 3-hydroxyalkanoate unit and lactate unit, and its manufacturing method
BRPI0718979-6A BRPI0718979B1 (en) 2006-11-21 2007-11-21 method for preparing a copolymer comprising lactate monomer unit and 3-hydroxyalkanoate monomer unit
CN200780043134XA CN101616954B (en) 2006-11-21 2007-11-21 Copolymer comprising 3-hydroxyalkanoate unit and lactate unit and method for preparing the same
US12/312,636 US8765402B2 (en) 2006-11-21 2007-11-21 Copolymer containing 3-hydroxyalkanoate unit and lactate unit, and its manufacturing method
EP07834159.1A EP2087025B1 (en) 2006-11-21 2007-11-21 Copolymer containing 3-hydroxyalkanoate unit and lactate unit, and its manufacturing method
JP2009538326A JP2010510372A (en) 2006-11-21 2007-11-21 Copolymer containing 3-hydroxyalkanoate unit and lactate unit and method for producing the same
AU2007322529A AU2007322529B2 (en) 2006-11-21 2007-11-21 Copolymer containing 3-hydroxyalkanoate unit and lactate unit, and its manufacturing method
JP2013110698A JP2013165734A (en) 2006-11-21 2013-05-27 Copolymer containing 3-hydroxy alkanoate unit and lactate unit and method of manufacturing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020060116233A KR100957776B1 (en) 2006-11-23 2006-11-23 Novel Copolymer of [poly3-hydroxybutyrate-co-hydroxypropionate-co-lactate] and Method for Preparing the Same

Publications (2)

Publication Number Publication Date
KR20080046796A KR20080046796A (en) 2008-05-28
KR100957776B1 true KR100957776B1 (en) 2010-05-12

Family

ID=39663526

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020060116233A KR100957776B1 (en) 2006-11-21 2006-11-23 Novel Copolymer of [poly3-hydroxybutyrate-co-hydroxypropionate-co-lactate] and Method for Preparing the Same

Country Status (1)

Country Link
KR (1) KR100957776B1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101630003B1 (en) * 2011-11-28 2016-06-13 주식회사 엘지화학 Method of preparing for 2-hydroxyalkanoate polymer
KR102311152B1 (en) * 2019-10-23 2021-10-13 경희대학교 산학협력단 Production of poly(3HB-co-3HP) from methane by metabolic engineered methanotrophs

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020083475A (en) 2001-04-27 2002-11-02 캐논 가부시끼가이샤 Binder resin containing polyhydroxyalkanoate, toner containing the binder resin, and image-forming method and image-forming apparatus which make use of the toner
KR20060121555A (en) * 2005-05-24 2006-11-29 한국과학기술원 Cells or plants having an producing ability of polylactate or its copolymers and method for preparing polylactate or its copolymers using the same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020083475A (en) 2001-04-27 2002-11-02 캐논 가부시끼가이샤 Binder resin containing polyhydroxyalkanoate, toner containing the binder resin, and image-forming method and image-forming apparatus which make use of the toner
KR20060121555A (en) * 2005-05-24 2006-11-29 한국과학기술원 Cells or plants having an producing ability of polylactate or its copolymers and method for preparing polylactate or its copolymers using the same

Also Published As

Publication number Publication date
KR20080046796A (en) 2008-05-28

Similar Documents

Publication Publication Date Title
KR100957773B1 (en) Novel Copolymer of [Poly3-hydroxypropionate-co-lactate] and Method for Preparing the Same
AU2007322528B2 (en) Copolymer comprising 4-hydroxybutyrate unit and lactate unit and its manufacturing method
AU2007322529B2 (en) Copolymer containing 3-hydroxyalkanoate unit and lactate unit, and its manufacturing method
EP1885857B1 (en) Cells or plants having a producing ability of polylactate or its copolymers and method for preparing polylactate or its copolymers using the same
KR100926492B1 (en) Novel Copolymer of [poly3-hydroxybutyrate-co-4-hydroxybutyrate-co-lactate] and Method for Preparing the Same
KR100957774B1 (en) Novel Copolymer of [polyMCL 3-hydroxyalkanoate-co-lactate] and Method for Preparing the Same
KR100957775B1 (en) Novel Copolymer of [poly3-hydroxybutyrate-co-MCL 3-hydroxyalkanoate-co-lactate] and Method for Preparing the Same
KR100926489B1 (en) Novel Copolymer of [Poly3-hydroxyvutyrate-co-lactate] and Method for Preparing the Same
KR100957776B1 (en) Novel Copolymer of [poly3-hydroxybutyrate-co-hydroxypropionate-co-lactate] and Method for Preparing the Same
KR100948777B1 (en) Novel Copolymer of [poly3-hydroxybutyrate-co-3-hydroxyvalerate-co-lactate] and Method for Preparing the Same
KR20100111766A (en) Method for preparing poly(lactate-co-glycolate) or poly(lactate-co-glycolate-co-hydroxyalkanoate) copolymers using cells or plants having producing ability of poly(lactate-co-glycolate) or poly(lactate-co-glycolate-co-hydroxyalkanoate) copolymers
KR100926488B1 (en) Novel Copolymer of [poly4-hydroxybutyrate-co-3-hydroxypropionate-co-lactate] and Method for Preparing the Same
KR100926491B1 (en) Novel Copolymer of [poly3-hydroxybutyrate-co-3-hydroxypropionate-co-4-hydroxybutyrate-co-lactate] and Method for Preparing the Same

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20130410

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20140318

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20150416

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20170328

Year of fee payment: 8

FPAY Annual fee payment

Payment date: 20180418

Year of fee payment: 9

FPAY Annual fee payment

Payment date: 20190401

Year of fee payment: 10